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ABSTRACT 
Background: Medication self-management capacity (MMC) is an individual’s cognitive and 
functional ability to self-administer a medication regimen as prescribed. Poor MMC is an issue in 
older adults often resulting in negative health outcomes and loss of independence. Therefore, 
understanding low-income older adults’ capacity to manage their medications may help identify 
individuals who are at risk for developing medication mismanagement and guide future 
intervention strategies based on individual need to promote safe medication use and healthy aging 
in place in the community.  
Objectives: 1) To determine the cognitive and physical functional deficiencies in MMC among 
low-income older adults, 2) To identify variables that predict deficiencies in MMC in this 
population, 3) To determine the impact of using pharmaceutical aids/services on MMC, and 4) To 
examine the association between MMC and emergency room (ER) visits.  
Methods: This was a cross-sectional study of older adult residents living in low-income housing 
buildings served by the RHWP. At a study interview, information on demographics, medical 
history, and medication use was collected. MMC was evaluated using the Medication Management 
Instrument for Deficiencies in the Elderly (MedMaIDE) tool. Cognitive and functional status, 
health literacy and depression symptoms were assessed. ER visits were determined retrospectively 
over the last six months Descriptive analyses were performed to identify cognitive and physical 
functional deficiencies in MMC. Linear regression analysis was conducted to identify variables 
that predict MMC and assess the relationship between MMC and using pharmaceutical aid/service. 
Logistic regression analysis was used to examine the association between ER visits and MMC.  
Results: A total of 107 participants were included, and 89% were African-American with an 
average age of 68.54 years (±7.23). They had an average of 4.92 (±2.85) comorbidities and used 
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approximately 8 (±4.12) medications on a regular basis. The mean total deficiency in medication 
management was 3 (±2.00) as assessed by MedMaIDE. Lacking medication knowledge was 
common among the participants: 69.16% could not name and 46% state the indication of all of 
their medications, and 38.32% did not how and when all of their medications should be taken. 
When controlling for ADLs and falls, the mean total deficiency score in MedMaIDE increased 
among those with an educational level equal to high school or less compared with participants who 
had a higher educational level than high school [β=1.32, 1.24, p= 0.0195, 0.0415, respectively], 
and participants who reported difficulty reading prescription medication labels or opening 
medication bottles compared with those who did not report any difficulties [β=1.18, 1.43, p= 
0.0036, 0.0047, respectively].  About 20.56% of participants were receiving assistance with 
medications from someone, and 79.44% used at least one pharmaceutical aid/service. However, 
receiving assistance with medications and using pharmaceutical aid/service were not significantly 
associated with MMC [p= 0.5334, 0.0853, respectively]. The participants reported a total of 23 
(21.5%) ER visits within six months. The adjusted model for age, educational level, number of 
comorbidities, and ADLs suggested that for every one-unit increase in the total deficiency score, 
the odds of ER visits increased by 1.23 (p=0.1809) times.  
Conclusion: Many older adults who lived in low-income housing had impaired capacity to manage 
their medications independently. They appeared to have inadequate medication knowledge, which 
affects their cognitive ability to manage medications. Low educational level and health literacy 
and reporting trouble reading labels or opening medication bottles were predictors to deficient 
MMC.  Future studies are needed to confirm whether or not MMC predicts those who may not 
able to remain living independently safely or who may need additional support with medications 
to remain independent. 
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CHAPTER ONE  
INTRODUCTION 
1.1 Older Adult Population and Poverty in the United States 
In the United States (U.S.), there has been tremendous growth in the older adult population 
since the baby boomer generation turned 50 in the mid of 1990s. In addition, advances in medical 
care services with increased evidence for using a multiple medication regimen to manage chronic 
diseases has contributed to older adults living longer independently with good health status.1 
According to a U. S. Census Bureau report, the older adult population age 65 years and older 
accounted for approximately 15% (47.8 million) of the total American population in 2015, and the 
older adult population increased by 1.6 million since 2014.2 By 2060, older adult population is 
expected to represent about 25% (98.2 million) of the total population and 19.7 million of this 
number will be people age 85 years and older. This means nearly one in four of the American 
residents will fall in this age group in 2060.2, 3  
Because of this population level trend, the total dependency and old-age dependency ratios 
are estimated to increase. The dependency ratios represent the potential burden of the dependent 
population, those under 18 years and those 65 years and over, on those in the working-age 
population (18 - 64 years). The total dependency ratio is the sum of youth and old age dependency 
ratio, which calculated by dividing the number of people in the dependent age groups (youth or 
older adults) by the number in the working-age group and then multiplying by 100.3,4 The total 
dependency ratios declined between 1990 and 2010 as the youth dependency ratio declined 
because the baby boomer generation reached adulthood. However, the total dependency ratio is 
proposed to rise from 59% in 2010 to 65% and 75% by 2020 and 2040 respectively, as the older 
adult population and the old-age dependency ratio is continuing to increase.3  
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Rapid growth in the older adult population will likely substantially increase the numbers 
of low-income older adults. However, the median household income increased between 2015 and 
2016 across all age groups and those with householders of 65 and older had median income 
increased by 1.5%, from $41,501 in 2015 to $42,113 in 2016. Yet, many older adults live on a 
limited income in the U.S. Half of all Medicare beneficiaries had incomes below $26,200 and 25% 
had incomes below $15,250 in 2016.5  
Policymakers in the U.S. aim to enhance economic security and independence and reduce 
poverty rates among older adult people. Therefore, the U.S. Census Bureau created an alternative 
measure of poverty, known as the Supplemental Poverty Measure (SPM) to overcome the concerns 
that the (traditional) official poverty measure is outdated and does not accurately reflect resident’s 
financial resources and geographic variations in housing costs. Unlike the official measure, the 
SPM reflects out-of-pocket medical spending including premiums, which is specifically 
significant for older adult people, who spend a larger amount of their household incomes on health 
care costs than younger people.4,5   
In 2017, the poverty threshold was $11,756 for an individual age 65 or older, and the 
official poverty rate was 9.2% in the U.S. However, the SPM rate was 14.1% among older adults, 
which results in over seven million older adults living below poverty rate based on SPM, compared 
to 4.7 million based on the official measure. The higher poverty rate under SPM is mainly because 
the SPM takes into account out-of-pocket medical expenses. Under both the official and 
supplemental measures, the national estimates of poverty rate among older adult increased with 
age and were higher among female, Black and Hispanic groups, and people with relatively poor 
health. Figure 1 illustrates the national estimates of poverty rates under both the official measure 
and SPM among older people by age subgroup, sex, race, and health status in 2017.5 
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Note: Numbers in millions (%) 
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As the low-income older population increases, many of them are living in subsidized 
housing to overcome the financial burden. The U.S. Department of Housing and Urban 
Development (HUD) estimates that nearly 800,000 older adults live in low-income housing 
settings and receive federal support to pay the rent.6 Generally, older adults who are eligible for  
residing in low-income housings are more likely to have physical and behavioral health issues, 
chronic conditions, and report fair or poor health compared to other older population. Moreover, 
this population is less likely to have an education beyond high school compared to other older 
people in the community. For instance, it has been reported that 40% older adults residing in low-
income housing had limited mobility and are in need of assistance with everyday activities such 
as toileting, eating, bathing, and dressing compared to 19% of other older homeowners. Moreover, 
one study reported that 66% of low-income older adult residents were overweight or obese and 
25% had diabetes.6 
1.2 Age-Related Changes in Cognitive and Physical Functional Abilities  
Changes or declines in physical functional ability and cognitive function are part of the 
aging process.7,8 These age-related changes substantially limit individual ability to perform one or 
more essential activities of independent living. Despite this fact, the number of older adults living 
in the community with difficulties in hearing, vision, cognition, ambulation, self-care, or 
independent living rises with age.1,3  According to the U.S. Census Bureau’s American Community 
Survey report (2008-2012), about 38.7% (15.7 million) of older adults reported one or more 
disabilities, and those aged 85 or older represented about 25% of them.9 Table 1.1 summarizes the 
prevalence of disability among the older adult population in the U.S. by type of disability and age. 
Among the older adult population with disabilities, 12.6% of them were living in poverty, and 
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older Blacks with the disability had the highest poverty rate (23.7%) compared to other race 
groups.9  
Table 1.1 Prevalence of Disabilities among American Older Adult Population in 2008-2012 10  
Type of Disability Total 
Age n (%) 
65-74 years 75-84 years 85+ years  
Ambulatory* 10,467 (66.5) 3,696 (63.6)  3,861 (65.2)  2,911 (72.8) 
Independent living* 7,523 (47.8) 1,978 (34) 2,796 (47.2) 2,749 (68.7) 
Hearing  6,354 (40.4) 2,030 (34.9) 2,400 (40.6) 1,924 (48.1) 
Cognitive* 4,529 (28.8)  1,311 (22.6) 1,655 (28)  1,562 (39.1) 
Self-care*  4,468 (28.4)  1,177 (20.2) 1,595 (26.9) 1,697 (42.4) 
Vision  3,028 (19.2) 959 (16.5) 1,075 (18.2) 994 (24.9) 
Note: Numbers in Thousands (%)  
* Ambulatory – Having serious difficulty walking or climbing stairs  
* Independent living – having a difficulty doing tasks alone, such as visiting a doctor’s office or shopping  
* Cognitive – having difficulty remembering, concentrating, or making a decision  
*Self-care – having difficulty bathing or dressing 
Another way to measure disability is using the ability to perform both basic activities of 
daily living (ADLs) such as bathing/showering, getting in/out of bed/chairs, dressing, eating, 
walking and using the toilet, and instrumental activities of daily living (IADLs), such as preparing 
meals, managing money, shopping for groceries, or managing/taking medication. Indeed, both are 
essential for safe independent living. The Medicare Current Beneficiary Survey analysis in 2013 
shows that approximately 30% of the beneficiaries in the community sittings reported at least one 
limitation ADLs and 12% reported having one or more limitations in IADLs.4  
In general, aging is a significant risk factor for cognitive decline including dementia and 
mild cognitive impairment (MCI). Dementia is a cognitive condition that is characterized by a 
decline in one or more cognitive function such as, loss of memory, attention, or language or 
executive functioning.10 Older adults may experience a significant decline in these cognitive 
functions that may interfere with independent living, specifically in performing IADLs.7,10 Unlike 
dementia, MCI may sometimes interfere with basic activities, but it may not be severe enough to 
affect older adults’ ability to perform IADLs. The prevalence of dementia is increasing by age. It 
Page 17 of 155 
 
was estimated that 5% of older adult ages 71 to 79 years had dementia and this number increased 
to 24% by ages 80 to 89 years, and 37% by ages 90 years and older. Another study showed that 
the prevalence of dementia in Black adults age 71 years and older was about 21% compared with 
11% of whites in the same age group. Dementia is more prevalent among females than males, it 
affects approximately 16% of older adult females compared to 11% of males.10 
Typically, the ability to perform day-to-day activities (ADLs and IDALs) requires a 
complex integration of multiple physiological systems such as the psychomotor, musculoskeletal, 
and the cardiorespiratory systems. Most of these systems are altered by age and presence of chronic 
conditions. In addition, the ability to perform ADLs and IADLs is affected by an individual’s 
cognitive ability, specifically executive cognitive function (ECF).7,8 ECF refers to the individual’s 
cognitive ability to engage in independent, appropriate, and self-caring behavior that involves 
coordination of simple tasks and ideas into more complex ones.7,8 An example of ECF is 
coordinating between planning, organizing, and problem-solving activities to perform medication 
management/administration, shopping, and dressing. Previous studies found that 40% to 80% of 
older adults who had Mini-Mental State Exam (MMSE) scores indicating normal cognitive 
function experienced executive cognitive dysfunction.8 
Consequently, older adults with physical and cognitive limitations will face challenges that 
affected their abilities to live independently in the community. The U.S. Department of Health and 
Human Services (HHS) estimates that about 7% of residents who reach the age of 65 will need 
some form of long-term care such as community-based long-term services and support (LTSS) 
which is mainly covered by Medicaid.1 
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1.3 Multimorbidity and Polypharmacy among Older Adults 
Multimorbidity has become more prevalent among older adults as life expectancy has been 
increasing and the population has aged. Multimorbidity is defined as co-occurrence of two or more 
chronic conditions/diseases that are not cured but can be controlled through pharmacological or 
non-pharmacological treatments.11,12 In 2008, 67% of Medicare beneficiaries in community 
settings reported living with two or more chronic conditions compared to 33% that reported none 
or one chronic condition. The prevalence of multimorbidity increased with age from 62% for those 
aged 65-74 years to 75.7% for those aged 75-84 years, and to 81.5% for those aged 85 years and 
older. Moreover, females had a higher prevalence of multimorbidity among all age groups 
compared to males. The most common chronic conditions among community-dwelling older 
adults were hypertension (56%), hyperlipidemia (42.8%), and ischemic heart disease (26.6%).11  
Specific combinations of chronic diseases are associated with increased risk of disability 
and functional limitations, including limitations in physical and cognitive function and  
ADLs.11 For example, having a stroke with diabetes, osteoporosis, or hip fracture, visual 
impairment with osteoporosis, and heart disease with cancer may lead to increased risk for 
disability. While, having a combination of heart failure with chronic obstructive pulmonary 
disease, depression, osteoarthritis, or cognitive impairment may lead to an increased risk of 
functional impairment.11 Moreover, older adults with multimorbidity are at higher risk of reporting 
poor quality of life, polypharmacy, adverse drug events, and other adverse outcomes such as 
hospitalization and death.11,12 
As the number of people with multimorbidity increases substantially with age, 
polypharmacy is often prevalent and unavoidable among the older adult population. There is 
growing evidence for using a multi-drug regimen to manage and control chronic diseases. For 
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example, a 79 year old woman with osteoporosis, osteoarthritis, type 2 diabetes, hypertension, and 
chronic obstructive pulmonary disease may require up to 12 medications and 19 doses scheduled 
in five different times daily based upon clinical practice guidelines.12 In the U. S., older adults are 
the major consumers of prescription drugs, accounting for about 34% of pharmacy expenditures. 
A recent Centers for Disease Control and Prevention (CDC) report showed that approximately 
89% of community-dwelling older adults reported using at least one prescription medication in the 
last 30 days, whereas almost 67% reported using three or more, and 50% reported using five or 
more prescription medications.13  
Although using multiple-medication regimens is an important health intervention to 
manage multimorbidity, polypharmacy may cause or contribute to potential negative 
consequences, especially among older adults who live independently in the community.  Unlike 
hospitals or nursing homes, older adults in the community often do not receive needed support or 
help from family members, caregivers, or professionals to prevent the potential consequences of 
medication misuse/mismanagement. This results in an increased risk of unintentional medication-
related problems which can lead to serious consequences, such as nonadherence, hospitalization, 
emergency room (ER) visits, and a loss of independence.16-18
1.4 Medication-Related Problems among Older Adults  
Medication nonadherence is one of the significant health problems among all age groups 
in terms of healthcare cost and utilization. Medication nonadherence is contributing to more than 
$100 billion in costs to the U.S. healthcare system annually and it is associated with more than 
125,000 deaths per year.14 Although using complex and multiple medication regimens to manage 
chronic diseases has been recommended by most current clinical guidelines, such complexity 
increases the potential for unintentional medication nonadherence. It has been estimated that more 
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than 50% of older adults do not take their prescription medications as prescribed.15  Previous 
studies showed that 27% of adverse drug events among older adults were preventable. Among 
these preventable events, 20% were related to medication nonadherence. Other studies also found 
that approximately 28% of hospital admissions, over 70% of medication-related emergency room 
(ER) visits, and 23% of nursing home replacements were secondary to medication 
nonadherence.15,16 
Research has established that decline in cognitive and physical skills required for optimal 
independent medication management can lead to unintentional medication nonadherence and 
medication errors.15,17 Many older adults have difficulty opening different types of prescription 
medication vials/packages, which is one of the required physical skills for independent medication 
management.17,18 In addition to older age, many other factors have been associated with the 
inability to open medication containers including Parkinson’s disease, rheumatoid arthritis, 
cognitive impairment, and impaired vision. Studies have shown that over 60% of older adults were 
unable to break a tablet, about 14% had difficulty opening a screw-top bottle, 45% a flip-top bottle, 
21% a blister pack, 24% a Dosett dose administration aid, and 64% a child-resistant bottle.17  
Reading or interpreting instructions or labels on medication packaging is one of the 
essential cognitive skills for independent medication management.17,18 However, it is not only 
older adults with vision impairment who are unable to read instructions on medication packaging.  
Even those with corrected vision report the same issue resulting in reduced medication 
management ability and adherence. Prior studies reported that self-treatment, lack of coordinated 
healthcare, recent hospitalization, impaired cognitive status, low socioeconomic status, and a 
complex medication regimen are factors contributing to poor medication self-management 
capacity in older adults.19,20 
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Despite these facts, the majority of community-dwelling older adults maintain the 
responsibility for managing their own medications. One study found that approximately 80% of 
community-dwelling older adults were responsible for managing their medications with no or little 
help from family members or caregivers while they experience a decline in their physical and 
cognitive abilities.20 Moreover, another study showed that only 27% of older adults who had 
physical difficulty opening their medication containers were getting assistance with their 
medications.17 Consequently, there has been a concern about medication self-management 
capacity among older adults because they are commonly using multiple medication regimens while 
they experience an age-related decline in their cognitive and physical abilities that are required for 
managing medication independently. 
1.5 Medication Self-Management Capacity (MCC) 
Numerous terms, including medication management capacity and medication self-
management/administration skills or capacity, are routinely used in the literature to describe a 
person’s ability to take his/her own medications. MMC has been defined as “an individual’s 
cognitive and functional ability to self-administer a medication regimen as it has been prescribed.”8 
A new conceptual model has defined MMC as, “the extent to which a patient takes medication as 
prescribed, including not only the correct dose, frequency, and spacing but also its continued, safe 
use over time.”14 According to these two definitions, MMC represents an individual’s ability to 
self-administer a medication correctly and safely, when this person has the desire to follow the 
medication regimen as prescribed by healthcare providers.  
Managing a medication regimen is one of the self-care activities that require a high level 
of integration and coordination between cognitive and physical skills. A wide range of cognitive 
and physical skills have been identified in the literature as requirements for optimal medication 
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management including, but not limited to, correctly identifying medications, opening and 
removing the medication from packaging, scheduling the medication regimen, and obtaining 
medication from the pharmacy or physician office.8,17 Table 1.2 includes the most frequent skills 
assessed by different validated instruments of MMC.  
Table 1.2 Most Frequent Skills Assessed by Different Validated Instruments of MMC17 
Medication Self-Management Skills* 
Physical skills  
 Open medication packaging  
 Remove medication from packaging  
 Fill a dose-administration aid (pill box) 
 Re-cover medication container  
 Split tablet  
 Measure a dose of liquid medication 
 Swallow pills or water  
 Administer non-oral dosage form  
 Access pharmacy and/or doctor to obtain 
medication  
Cognitive skills  
 Read standard medication label  
 Describe indications & dosage regimen of 
own medications  
 Demonstrate setting out 24 hours of 
medication 
 Read and interpret additional instructions 
 Name and identify all of own medications 
 Judgment and consequences (e.g. know 
what to do in missing a dose situation) 
 Perform calculations 
 Differentiate medication by color, size or 
shape  
* The exhaustive list of medication management skills was reported in a review paper that identifies instruments 
used in clinical practice to assess patients’ ability to manage medications. 
This study will be guided by the conceptual model of medication self-management.14 This 
model provides a better understanding of the tasks associated with the optimal management of 
medications and sustaining safe and correct use over time in community settings. The authors of 
this model deconstruct medication self-management into a series of six steps that a patient must 
perform to successfully manage their medications independently (Figure 1.2). These steps are fill, 
understand, organize, take, monitor, and sustain. The authors also highlighted the lack of a 
comprehensive measure of MMC that can be used to evaluate the full range of skills required by 
patients to successfully manage medication regimens.14  
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The term medication adherence is generally used to describe the patient's’ medication-
taking behavior over time. It is defined by the World Health Organization defines medication 
adherence as "the degree to which the person’s behavior corresponds with the agreed 
recommendations from a health care provider.”21 There are many different factors that affect 
medication adherence such as medication factors, patient factors, physician factors, system-based 
factors.21,22 Non-adherence behaviors are broadly categorized into two types, intentional and 
unintentional non-adherence. Intentional non-adherence occurs when the patients purposely decide 
not to take or comply with the medication instructions, despite having the ability to take 
medications as instructed. This type of non-adherence is related to patients’ beliefs, attitudes and 
expectations that influence patients’ motivation to take and sustain taking medications as 
prescribed.21,22 In contrast, unintentional non-adherence occurs due to capacity (i.e. forgetfulness, 
vision impairment, and dexterity deficiency) or resources (i.e. problems of accessing prescriptions 
or cost) limitations that prevent patients from complying with medication instructions.21,22 
Therefore, the current medication adherence measures are often focused on measuring whether 
you actually take medications or not. However, medication mismanagement usually occurs 
unintentionally by patients due to lack or insufficient skills that are necessary for optimal 
medication management regime.14 Therefore, measurements of MMC typically determine factors 
of whether or not the patients can manage medications independently. 
Assessing older adults’ capacity to manage their medication independently is not routinely 
performed in clinical practice. Previous studies used measures of medication adherence such as 
self-report, pill count, and pharmacy claims data to evaluate MMC.15, 21 However, measures of 
medication adherence provide limited insight on subsequent tasks associated with successful 
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medication self-management and are generally focused on how often medications are taken or 
refilled. On the other hand, evaluating patients’ capacity to manage a medication regimen, using a 
standardized MMC assessment tool, provides information about how the medication is taken by 
patients (i.e. the accuracy of medication use).15, 21 While several instruments have been developed 
to evaluate older adults’ MMC, most were designed to identify cognitive and physical barriers to 
safe and accurate medication use. Additionally, there is a variation in medication management 
skills that are assessed in these instruments. However, the most frequently assessed skills are 
opening and removing the correct dose from medication packaging, reading standard medication 
labels, and recalling information, which is not a comprehensive evaluation of MMC.17,18,23 
The majority of MMC instruments utilize two types of assessment methods, either using 
the patient’s own medications or using simulated medication regimens, each with strengths and 
limitations. The simulated approach may help standardize the assessment process and it is useful 
when the patient’s own medications are not usually available or the patients are reluctant to bring 
in their medications for testing. However, using the patient’s own medications approach is 
preferred because it causes less stress on older adults, and it reflects what they do routinely in real 
life (home) compared to using an unfamiliar simulated approach.17,18,23 
Figure 1.2 Model of Medication Self-Management14 
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CHAPTER TWO 
LITERATURE REVIEW   
Measuring Medication Self-Management Capacity 
2.1 Introduction  
Managing a medication regimen is one of the self-care activities that is important for safe 
and independent living. Patients should have sufficient capacity to self-manage medication to 
attain positive outcomes and maintain independence.  The capacity of self-managing medication 
refers to a patient’s cognitive and physical skills to self-administer medications as prescribed.  
Typically, it is a measure of a patient’s ability to follow the prescription directions, when they have 
the desire to do so. Whereas medication non-adherence may be a result of intentional or 
unintentional factors, this is not the case in medication mismanagement. Poor or limited ability to 
manage medications normally occurs unintentionally due to functional limitations, which can be 
cognitive, physical or both. This could be a consequence of health deterioration or aging, which 
negatively affects individuals’ self-care ability. As the patients’ medical and therapeutic needs 
increase, self-care ability decreases.1,2 The importance of assessing patients’ ability to manage 
medications, using an objective and validated tool, has been elucidated in the literature. It can be 
used as a guide to target medication interventions based on patients’ needs to enhance the correct 
and safe use of medications among geriatric patients with chronic diseases. Additionally, it can be 
a significant indicator of self-care or cognitive function deficits that lead to loss of independence.1-
5 
However, assessing patients’ capacity to manage medications independently is not 
routinely performed in clinical practice. Usually, healthcare providers assess a patient’s ability to 
manage their medication using professional judgment based on the patient’s medical conditions or 
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caregiver report. This method is subjective and biased which may lead to over or under estimating 
the patient’s ability to manage medications. Additionally, some health professionals use 
medication adherence measures, either subjective or objective, as a proxy for a patient’s ability to 
manage medications. Most adherence measures are limited to how often the medications are taken 
or refilled rather than how the medications are taken by the patient. Even the use of functional 
assessments such as MMSE, ADL, or IADL, which can predict patients’ cognitive or physical 
ability, may not necessarily assess the required skills for optimal managing of medications. 2,6 
Therefore, there are numerous tools that have been developed to assess patients’ capacity 
to manage medications independently.  These assessments have been subjected to a varying level 
of validity and reliability testing. However, none of the previously published assessment 
instruments have been recommended as a gold standard to be used in clinical practice or research 
studies. Previous literature reviews identified and evaluated those available instruments assessing 
patients’ functional ability to manage medications in outpatient settings.2–5 However, there has 
been more recent innovation and expansion in the area of instrument development assessing 
patients’ ability to manage medications. There have been newly published instruments that were 
not included in previous literature reviews. For this review, the included instruments were limited 
to those based on with direct observation.   
The aim of this review was to identify the available assessment instruments designed to 
assess patients’ ability to manage medications independently and identify reliable and valid tools 
that could be used in clinical practice and research. Reviewing the medication management 
assessment instruments can help healthcare professionals to select the appropriate tools to be used 
based upon the tools’ characteristics and psychometric evaluation of its performance. Assessing 
patients’ ability to manage their own medications using a validated instrument may help to identify 
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barriers for the appropriate and safe use of medications. Also, it helps to plan the intervention to 
enhance their performance and safe use of medications based on the potential needs. This may 
ensure that older adult patients are aging safely and independently in their own homes as long as 
possible. 
2.2 Methods  
Literature Search  
To review the existing medication management assessment instruments, a comprehensive 
literature review was conducted using the following electronic databases: PubMed/MEDLINE, 
CINAHL Complete, PsycINFO, Embase, and International Pharmaceutical Abstracts (IPA).  A 
broad search was conducted due to the lack of a standard definition and terminology of patients’ 
capacity to self-manage medication in the literature.  The relevant published studies were targeted 
using combinations of key words and medical subject headings (MeSH) in PubMed. The search 
strategies used in the other databases were built to reflect similar keywords and MeSH terms used 
in the PubMed search as described in Table 2.1. This review was limited to articles published in 
English and after 2009 to capture any tool that were not included in the previous review papers. 
The final search strategy was performed in October 2018. Bibliographies of the selected articles 
were also screened to identify any other relevant articles.  
Review Process  
The final search yielded a combined total of 3,856 articles. After eliminating the duplicate 
studies (n=1,360), a total of 2,496 articles remained for initial screening by title and abstract.  Two 
authors (Slattum, P.W. & Badawoud, A.M.) reviewed the titles and the abstracts for all the 
retrieved articles independently.  The following criteria were used to identify all relevant articles:  
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1. Preliminarly study introduced/proposed an assessment instrument developed to assess 
patients’ or informal caregivers’ capacity to manage their medication in outpatients or 
intend to assess the patients ability to self-manage of medications after hospital 
discharge.    
2. Assessed the required skills to successfully manage a whole/complete medication 
regimen. 
3. Discussed the psychometric evaluation of the instrument performance, which may 
include reliability, validity, or both data.  
4. Provided sufficient required details to be replicable in clinical practice.  
Any articles that: 1) were not relevant to the review topic, 2) introduced an assessment 
measure for adherence, self-care, disease management, or inpatient self-medication program, 3) 
introduced an assessment tool to assess medication management among pediatric patients or 
formal caregivers managing the medications of another person, or 4) described a tool to assess 
patients’ ability to manage one specific complex dosage forms, such as inhalers, or injectable 
medications.   
2.3 Results 
A total of 16 papers were identified, which corresponded to 4 literature reviews and 12 new 
studies. The flow chart in Figure 2.1 illustrates the screening and review process. Of the 16 papers 
identified describing development and/or validation of instruments that were designed to assess 
patients’ medication management capacity, 26 instruments were identified. While 17 instruments 
were obtained from the review papers7–23, 9 were newly published (3 were described in 2 separated 
papers) since the published reviews.24–35 These 26 instruments are listed in Table 2.2.  
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Characteristics of the Studies   
The primary validation study for each instrument is described in Table 2.3, illustrating 
instrument name (authors), design, aim, sample and psychometric evaluation.  Of the 26 studies 
reviewed, 20 were conducted in the U.S., three in Canada, and one each in United Kingdom 
(Scotland), Sweden, and South Korea. The design of almost all studies were cross-sectional (25), 
except one (DRUGS) which was initially validated in a cross-sectional study then followed by a 
prospective study.8 Most of the validation studies included a reasonable sample size of > 30 
subjects, except studies with five instruments that assessed small sample sizes (<30) (Home-Rx, 
Show Back, Patient’s barriers to compliance, SM Task, S-5).17, 19, 24, 28, 32  
Content Validity  
Of the 26 studies reviewed, studies with 24 instruments were subjected to some sort of 
content. However, the studies with two instruments (Show Back and S-5) reported only content 
validity.28, 32 In both studies, the content validity was conducted simply among a panel of experts 
and a sample of older adult patients.  
Construct Validity  
Most of the instruments were designed to assess outpatients’ capacity to take their 
medications except two of them (PA and S-5).15, 32 The S-5 and PA instruments were developed 
to determine the readiness of hospitalized patients to self-manage their medications before they 
were discharged.15, 25 Of the 25 studies, 18 studies included a sample of apparently healthy older 
adults with an average age of ≥ 65 years. The other seven studies assessed medication management 
capacity among patients with HIV (MMT and MMT-R),22, 23 schizophrenia (MMAA and 
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VRAMMA),9, 13 Parkinson’s disease (PillQ),29 stroke (S-5),32 and Alzheimer ’s disease and 
dementia (Pillbox Test).27 
 In 20 studies, the correlation between the subject’s ability to manage medications and 
cognitive function was tested in order to validate the ability of the proposed instrument to assess 
cognitive medication management skills. In six studies, patients’ performance on ADL, IADL, or 
both tests was used to correlate the physical medication management ability with functional status 
(DRUGS, HMS, MAT, MedMaIDE, MMT-R, PillQ).7, 8, 10, 11, 16, 23, 29 Additionally, patients’ 
dexterity of handling medication bottles (RAT) and grip strength (SM Task) were used to correlate 
physical function with medication management ability.19, 35 Eight studies examined the correlation 
between inability to manage medications independently and both physical and cognitive functional 
impairment (DRUGS, HMS, MAT, MedMaIDE, SM Task, MMT-R, PillQ, and RAT).7, 8, 10, 11, 16, 
19, 23, 28, 35 These analyses confirm that medication management ability decreases when cognitive 
or physical functional status deficits increase. 
 The significant association between medication management performance and medication-
related outcomes (e.g. medication adherence, medication related-problems, medication regimen 
complexity, and the number of medications taken) was reported in studies with nine instruments. 
The association between medication management capacity and self-reported adherence was 
assessed in five studies (MMPT, MAI SM task, MMT, and SMAT).12, 14, 19, 22, 33, 34 Objective 
measures of medication adherence (e.g. pill count, medication refills) were used to validate two 
instruments (MMAA and MedMaIDE).9,16 The performance on the ManageMed instrument was 
associated with the number of medications taken; PA instrument was associated with medication 
related-problems; SMAT was associated with medication regimen complexity.15, 31, 33, 34 
Page 34 of 155 
 
In studies with five instruments, medication management performance was compared with 
other measures of medication management capacity. The performance as measured by the DRUGS 
and MMPT instruments was significantly associated with self-reported medication management 
capacity.7, 8, 12 The patients’ performance as measured with the PA instrument was compared with 
self-medication ability during hospital admission.15 In addition, the comparison between two 
objective measures of medication management was reported in primary validation studies with 
two instruments, the VRAMMA instrument was compared with MMAA, and Home-Rx was 
compared with ManageMed. 13, 31 
Reliability 
The reliability data was not reported for 14 instruments, while 12 of them were subjected 
to some sort of reliability testing (i.e. internal consistency, inter-rater and/or test-retest 
reliability).7-10, 16, 20-23, 28, 31, 33-35 Only studies with two instruments reported complete and 
acceptable reliability evidence including inter-rater and test-retest reliability, and internal 
consistency (MedMaIDE, SMAT).16, 33, 34 Studies with five instruments reported only internal 
consistency (MMAA, HMS, MM Test, and RAT).20, 9, 10, 35 All instruments that reported internal 
consistency had acceptable Cronbach's alpha coefficient values (i.e. > 0.70), except the HMS 
instrument, which had low internal consistency (0.38).10 Show Back and RACT instruments were 
subjected to only test-retest reliability.21, 28 
Selected Instrument Characteristics  
Table 2.2 provides details of each instrument, illustrating its purpose as reported by the 
authors, number of items, medication management abilities and skills assessed, scoring scale, and 
time for administration.   Of the 26 instruments, both validity and reliability data were reported for 
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12 instruments,7-10, 16, 20-23, 28, 31, 33-35  two of which tested validity using simply content experts’ and 
patients’ opinion (Show Back and S-5).28, 32 Only two instruments had been subjected to content 
and construct validity testing as well as full reliability testing (MedMaIDE, SMAT). 16, 33, 34 
Almost all the identified instruments (25) were designed as performance-based assessment 
tools, where the patients’ medication management skills were observed during face-to-face 
interviews.6-28, 31-36 One self-reported instrument was identified where the patients were asked to 
describe their medication regimen and colors and shapes of the tablet (PillQ).29, 30 The identified 
instruments are categorized according to the administration method used: a) performance-based 
instruments using patients’ own medications [5 instruments], b) self-reported instrument using 
patients’ own medications [1 instrument], c) performance-based instruments using simulated 
medication regimen [14 instruments], d) performance-based instruments using both simulated and 
patients’ own medication regimens [4 instruments], e) performance-based instruments using a 
pillbox [2 instruments].  
The main purpose of almost all of the instruments was to assess older adult patients’ ability 
to take medications independently at home,6-14, 16-31, 33-35 except for the PA tool, which was 
designed to assist with discharge-planning decisions in hospitals and the S-5 tool used to assess 
patients’ readiness to self-medicate after stroke.15, 32 Most of the identified instruments covered 
both cognitive and physical abilities to manage medications. 6-12, 14-25, 27, 28, 31-35 There were three 
instruments assessing only the cognitive ability to manage medications (VRAMMA, Medi-Cog, 
and PillQ).13, 26, 29 Sensorial ability to manage medication was assessed in eight instruments, and 
these instruments covered cognitive and physical abilities as well (Patient’s barriers to compliance, 
MMEI, MMAA, S-5, MAI, PA, SMAT, Pillbox test).14, 15, 17, 18, 27, 32 -34 
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The number of items included in each instrument varied from four to 44 items/questions 
and that was based upon the number of medication management skills that were assessed in each 
instrument. The medication management skills that were assessed varied per instrument. However, 
the most frequently assessed skills were identifying medications by reading the labels or recalling 
the name or appearance, opening and removing the correct dose from packaging, reading standard 
medication labels, and stating dosing time. In the instruments that used patients’ own medications, 
cognitive ability to manage medications was assessed by asking the patients to identify/name all 
medications and state why and when each medication is taken. Physical ability was assessed by 
asking the patients to open/close medication vials/bottles, and removing the required dose from 
packaging. The instruments that used a simulated medication regimen tested patients’ cognitive 
ability to manage medications by asking them to read and interpret prescription labels (in standard 
font size or in different font sizes) and/or organize a pillbox and perform some simple calculations. 
Physical ability was determined by assessing patients’ ability to open/close child-resistant caps 
and/or different sizes of vials, and the ability to remove pills from vials.  The other instruments 
determined the cognitive medication management ability by assessing what the patients knew 
about their medications (name, dose, indication, and timing) and assessed physical ability using 
standardized kits of prescription vials/bottles. Medi-Cog assesses only the cognitive function as 
patients are asked to fill in the correct number of “pills” in the correct compartments of a pillbox 
using a paper and pencil.26 In contrast, the Pillbox test assesses both cognitive and physical ability 
by requiring patients to read standard prescription labels on five pill bottles containing colored 
beads (standard pill size) to fill a weekly pillbox.27  Sensorial ability to manage medication was 
assessed primarily by asking patients to distinguish tablets by color and/or shape in all instruments.  
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The scoring system varied among instruments, however, most of them utilized the response 
format of yes and no (able and unable) and summed up all the yes or no responses at the end of 
the assessment. The scoring system was not reported for four instruments (MAI, patient’s barriers 
to compliance, SM Task, and RACT)14, 17, 19, 21 The VRAMMA and Pillbox Test had multiple 
scoring systems, and the SMAT instrument had five scales, and each one was scored differently.13, 
27, 33, 34 
The administration time may vary based upon the number of medications the patients were 
taking when patients’ own medications were used for testing. Additionally, patients with cognitive 
impairment may take a longer time to complete the assessment in all types of instruments. The 
administration time was not reported in studies of eight instruments (PillQ, RACT, MMPT, 
VRAMMA, ManageMed, SMAT, Medi-Cog, Pillbox Test).12, 13, 21, 26, 27, 29, 31 The administration 
time for the instruments that used patients’ own medications ranged from 5 to 45 minutes. Most 
instruments that used standardized medication regimens for assessment were reported to take less 
than 20 minutes to complete with the exception of the MMAA instrument, which reported 45-60 
minutes to complete.9 The instruments assessing medication management skills by using both 
patients’ own medications and standardized medication regimen took about 30 minutes to 
complete.  
2.4 Discussion & Conclusion  
Discussion 
Recently, the area of developing a standardized instrument to quantify medication self-
management capacity has been growing. A number of instruments have been developed to assess 
the medication management skills required by patients for safe and accurate use of medications. 
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Although some of the instruments identified for this evaluation were reviewed in previous papers, 
nine newly published instruments were identified. Most instruments were designed to identify 
cognitive and physical barriers to successful medication management. Despite this common 
rationale, there was inconsistency among the instruments in the specific skills that should be 
assessed. In addition, some of the instruments have not generated reliability evidence and some of 
them reported limited evidence of reliability. Because medication management is a complicated 
construct involving several skills and behaviors, a wide variety of measurements and comparisons 
were used to validate the instruments.  Most of the instruments were validated by testing its 
association with at least one related construct measure such as cognitive function, ADL, IADL 
and/or adherence. Consequently, the evidence is insufficient to recommend a single instrument to 
be used in clinical practice or research as a “gold standard.” 
Clinical Applicability 
Despite this wide range of attempts to develop a reliable and valid instrument assessing 
medication management capacity, none of the instruments has enough evidence to be 
recommended as a standard measure in clinical practice or research. A couple of earlier reviews 
nominated some instruments as promising measures for future studies based on the current 
reliability and validity evidence, and/or other characteristics such as length of the instrument, 
administration method, scoring system, and skills assessed. However, the recommendations made 
in the earlier reviews were inconsistent. Both reviews selected DRUGS, MedMaIDE, and MMAA, 
but there was controversy about recommending MMPT, HMS, MAT, MM Test, and MMEI.3,4 
Therefore, it is important to propose specific desirable characteristics for a suitable 
measurement instrument intended to be used in clinical settings and studies. In Table 2.4, a list of 
ideal assessment instrument characteristics was created based on the findings of this review and 
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previous reviews.  Regardless of the purpose of the instrument, the ideal assessment instruments 
share some basic characteristics. In general, the ideal instrument should be valid and reliable, 
objective and quantitative, easily administered with an uncomplicated scoring system and provide 
clear and interpretable results. In addition, it should be brief, administered in less than 30 minutes 
with minimal training and materials. The ideal instrument assessing medication management 
should assess both cognitive and physical abilities, but at the same time should not be 
overwhelming for the patient (Table 2.4). 2–4 
Using the patient’s own medication regimen to assess MMC causes less stress on older 
adults (non-threatening), and reflects what they do routinely in real life (home) compared to using 
an unfamiliar simulated approach.  Sometimes, patients are reluctant to bring their medications for 
review, especially older adult patients who may anticipate that poor performance may cause loss 
of independence. In contrast, using a simulated medication regimen for assessments needs special 
training and preparation of a standardized kit of medication labels and bottles. As a result, those 
instruments may not be easily portable. However, it is useful when patients’ medications are not 
available, and helps to standardize the assessment process to compare between different groups 
and/or changes over time.2,4 
Based on the current evidence, several cognitive and physical skills were recommended to 
be assessed for successful medication management, regardless of the methods each instrument 
uses to assess these skills. The ideal assessment instrument should assess some basic cognitive and 
physical tasks required to be performed by patients to manage medications independently in real-
life. In terms of cognitive skills, the patients should be able to identify medications by whatever 
means (i.e. reading the label or recognize the appearance of medication), state indications, and 
describe dosing time and medication instructions.  Additionally, knowing how and when to order 
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more medications (i.e. refills) was considered one of the basic cognitive skills that should be 
assessed by ideal medication management instruments. According to the medication self-
management capacity model, the patients should be able to sustain the safe use of medication by 
being aware of the ongoing supply of medications.36 However, MedMaIDE is the only instrument 
that determines patients’ knowledge of how to get their medications. In term of physical skills, 
patients’ ability to open their medication packaging and remove the required doses should be 
assessed. Most of the instruments assessed patients’ ability to open child-resistant vials because 
they were developed in the U.S. where it is the most common type of packaging in the pharmacy 
community.  
When managing complex and multiple medication regimens, some assessment measures 
require that patients be able to split the tablets and be able to handle and administer non-oral 
medications (such as different types of inhalers, injectable medications, eye and ear drops, and 
nasal sprays). However, few instruments assessed patients’ ability to manage non-oral dosage 
forms and none of the instruments used a standardized method for assessing the required skills to 
manage non-oral medications. In addition, dose administration aids such as pillboxes are 
commonly used by patients required to take multiple medication regimens. Therefore, when the 
patients depend on a pillbox to organize their multi-drug regimens, their skills to correctly organize 
and fill the pillbox or use a pillbox filled by a caregiver should be assessed.  
Based on this review, instruments utilizing the patients’ own regimen are more applicable 
for use in clinical settings. DRUGS and MedMaIDE met most of the proposed characteristics for 
ideal instruments designed to assess medication management capacity. In addition, they reflect 
what the patients do routinely in real life (at home), do not require special preparation or materials, 
and cause less stress on patients compared to using an unfamiliar (simulated) approach. 
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MedMaIDE is the instrument that demonstrates the most promise for use in future research studies. 
It is the most comprehensive instrument compared to other identified instruments; the items 
included in MedMaIDE consolidate the required tasks associated with managing prescription. It is 
the only instrument that determines a patient’s knowledge of how to get their medications, and is 
not limited to oral medications. In addition, it is reasonable in length, taking approximately 30 
minutes to administer. 
This literature review has several limitations.  This review is limited to English language 
publications. In addition, the methodological quality of validation studies was not systematically 
assessed or reviewed. The list of the ideal instrument characteristics proposed is somewhat 
subjective, however, it was adapted from previous literature. The selection of instruments based 
on the proposed criteria is subjective and suited to studies done in clinical settings. There might be 
other factors that affect patients’ capacity to manage medication (such as motivation for take 
medications, patients’ perception about medication, and financial ability) that are not addressed in 
the current tools. These factors were beyond the scope of this review. Finally, only the initial 
validation studies were discussed in this review, which might omit some details or validation 
evidence studied later by the same group who developed the instrument or another independent 
group.   
Conclusion 
A number of instruments assessing medication management capacity have been published 
recently. However, the medication management skills assessed and the methods used to assess 
these skills varies between instruments. The majority of available instruments may help to 
determine cognitive and physical barriers to safe and accurate medication use, and guide the 
interventions based on potential patient needs. DRUGS and MedMaIDE demonstrate the most 
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characteristics consistent with the proposed criteria for an ideal instrument designed to assess 
medication management capacity that are applicable for clinical use.    
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Table 2.1 Search Strategy for Each Database 
Databases Research Strategy 
PubMed/M
EDLINE 
(("Self Care"[MeSH] OR "Self Efficacy"[MeSH] OR "Self Administration"[MeSH] OR "Patient 
Compliance"[MeSH] OR "self care"[All Fields] OR "Medication Adherence"[MeSH] OR "self 
management"[All Fields] OR "self administration"[All Fields] OR "self medication"[All Fields] 
OR "self efficacy"[All Fields] OR "patient compliance"[All Fields] OR "medication 
adherence"[All Fields]) AND ("prescription"[All Fields] OR "prescriptions"[All Fields] OR 
"medication"[All Fields] OR "medications"[All Fields] OR "Medication Therapy 
Management"[MeSH] OR "medication management"[All Fields])) AND (“assessment”[ti] OR 
“assessments”[ti] OR “assess”[ti] OR “assessing”[ti] OR "validity"[ti] OR "validation"[ti] OR 
“validating” [ti] OR "reliability"[ti] OR "Psychometrics"[MeSH] OR "psychometric"[ti] OR 
"psychometrics"[ti]) 
CINAHL 
Complete 
((MH "Self Care+" OR MH "Self Administration+" OR MH "Self Medication" OR "self care" OR 
"self efficacy" OR "self administration" OR "patient compliance" OR "medication adherence" OR 
"self management") AND (MH "Medication Management" OR MH "Medication Compliance" 
OR "prescription" OR "prescriptions" OR "medication" OR "medications" OR "Medication 
Therapy Management" OR "medication management")) AND TI (“assessment” OR 
“assessments” OR “assess” OR “assessing” OR "validity" OR "validation" OR “validating” OR 
"reliability" OR "psychometric" OR "psychometrics") 
PsycINFO 
((IndexTermsFilt: ("Self-Efficacy")) OR (IndexTermsFilt: ("Drug Self Administration")) OR 
(IndexTermsFilt: ("Self-Management"))) OR((Any Field: ("self care")) OR (Any Field: ("self 
efficacy")) OR (Any Field: ("self administration")) OR (Any Field: ("patient compliance")) OR 
(Any Field: ("medication adherence")) OR (Any Field: ("self management")))) 
AND(((IndexTermsFilt: ("Prescription Drugs")) OR (IndexTermsFilt: ("Drug Therapy"))) OR 
((Any Field: ("prescription")) OR (Any Field: ("prescriptions"))OR (Any Field: ("medication")) 
OR (Any Field: ("medications")) OR (Any Field: ("Medication Therapy Management")) OR (Any 
Field: ("medication management"))))) AND ((title: ("assessment") OR title: ("assessments") 
ORtitle: ("assess") OR title: ("assessing") OR title: ("validity") OR title: ("validation") OR title: 
("validating") OR title: ("reliability") OR title: ("psychometric") OR title: ("psychometrics"))) 
Embase 
("self care" or "self management" or "self administration" or "self medication" or "self efficacy" 
or "patient compliance" or "medication adherence").mp. [mp=title, abstract, heading word, drug 
trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword, 
floating subheading word, candidate term word] AND   ("prescription" or "prescriptions" or 
"medication" or "medications" or "medication management").mp. [mp=title, abstract, heading 
word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, 
keyword, floating subheading word, candidate term word] AND ("assessment" or "assessments" 
or "assess" or "assessing" or "validity" or "validation" or "validating" or "reliability" or 
"psychometric" or "psychometrics").ti. 
IPA 
(("self care" OR "self efficacy" OR "self administration" OR "patient compliance" OR 
"medication adherence" OR "self management") AND ("prescription" OR "prescriptions" OR 
"medication" OR "medications" OR "Medication Therapy Management" OR "medication 
management")) AND TI (“assessment” OR “assessments” OR “assess” OR “assessing” OR 
"validity" OR "validation" OR “validating” OR "reliability" OR "psychometric" OR 
"psychometrics") 
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Figure 2.1 Screening and Reviewing Process 
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Table 2.2 Medication Management Capacity Assessment Instruments  
   
MM 
abilities 
assessed 
MM skills assessed   
Instruments Purpose* 
#
 item
s 
C
o
g
n
itiv
e 
P
h
y
sica
l 
S
en
so
ria
l 
Skills assessed  
S
co
rin
g
 
S
ca
le 
T
im
e 
(m
in
s)
# 
Performance-based instruments use patients’ medication regimen  
DRUGS7,8 
To examine the patient's capacity to manage 
his/her own medication regimen, and 
standardize the brown bag review   
4 + +  
1) Identify meds, 2) open bottles/vials, 3) remove 
dose from package, 4) state time schedule  
0-100 5-15 
MedTake6 
To quantify seniors’ ability  to  take  oral  
drugs  safely, standardize the brown bag 
review   
4 + +  
1) Identify meds & recall med names, 2) open 
bottles/vials & remove dose from package, 3) state 
indication, food/water coingestion, and 4) timing  
0-100 30-45 
MedMaIDE16  
To identify the deficiencies in older adults’ 
ability to take their medication at home 
 Assess different dosage forms  
20 + +  
1) Medication knowledge (name all drugs and 
describe full regimen including indication, rout of 
administration, dose and time)  
2) Medication taking ability (filling a glass of water, 
sip enough water, open bottles/vials, remove dose 
from package, and demonstrate admiration method 
for oral and  non-oral dosage form) 
3) Knowledge about ongoing supplies (identify 
existing refills, name of pharmacy or physician 
office, and available resources)    
0-13 30 
HOME–
Rx24,25 
To assess 
an older adult’s ability to manage medication 
routines in the home and to identify at-risk 
behaviors by home health occupational 
therapists 
• Assess different dosage forms 
16 + +  
knowledge of medications,   
Recall information, maniple of medication bottles 
and/or syringe (if used by pt), and calculate 
medication doses 
 
1-16 30-45 
Show Back 28 
To assess older adult medication self-
management proficiency 
5 + +  
1) Identifying meds, 2) explaining the indication, 3) 
Organizing pillbox, 4) describing the administration 
process for injectable and inhaled meds. or pills 
requiring cutting, 5) Describing the timing of doses 
0-100 22 
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MM 
abilities 
assessed 
MM skills assessed   
Instruments Purpose* 
#
 item
s 
C
o
g
n
itiv
e 
P
h
y
sica
l 
S
en
so
ria
l 
Skills assessed  
S
co
rin
g
 
S
ca
le 
T
im
e 
(m
in
s)
# 
Self-reported instruments use patients’ medication regimen  
PillQ29,30 
To assess decline in cognitive functioning 
and its impact on ADLs in patients with PD 
by asking patients or caregivers about 
whether patients can independently manage 
their medications 
1 
 
+   
Ask the patients to clearly describe medications 
including doses (mg. or color of tablet) and 
medication schedule 
0-3  
Performance-based instruments use standardized medication regimen  
Patient's 
barriers to 
compliance17 
To assess functional abilities that can make 
compliance difficult for the older people 
5 + + + 
Recall, read small font, differentiate tablets by color 
and size, open different sizes of vials and liquid 
containers, and interpret instructions    
 < 10 
MMEI18 
To assess the patient's 
functional ability to take medication 
5 + + + 
1) Read Rx label, 2) Open and close a child-resistant 
& a non-child-resistant vials, 3) remove tablets from 
vails, 4) Interpret instruction, & 5) differentiate 
tablets by color. 
0-5 < 5 
SM Task19 
To assess patients’ ability to plan medication 
& successfully administer a new medication 
5 + +  
1) Read the Rx label, 2) interpret the Rx instructions, 
3) open the pill bottle; 4) cut pills when required, and 
5) organize weekly pillbox  
 < 20 
MM Test20 
To assess high-level adaptive functioning in 
people with early dementia & MMC  
17 + +  
1) Identify med, 2) Recall number of pills, 3) 
calculate days’ supply, 4) explain med regimen, 5) 
know the indication, 6) open vial, 7) remove pills 
from the vial, & 8) describe the medication vial  
0-46 < 5 
RACT21 
To assess patient's capacity to adhere to a 
medication regimen before its initiation 
11 + +  
1) Read and interpret  Rx & auxiliary labels, 2) 
open/close & remove/return pills from vials, 3) what 
should be done when missing a dose, or having 
adverse effects  
  
MMT22 
To assess patients’ ability to comply to anti-
retroviral medication regimens 
20 + +  
1) Organize weekly pillbox, 2) calculate day’s 
supply, 3) read and interpret Rx & axillary labels, 4) 
what should be done when missing a dose, or having 
adverse effects 
0-100 15-25 
MMT-R23 
To assess patients’ ability to comply to anti-
retroviral medication regimens 
11 + +  Same as MMT 0-10 10 
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MM 
abilities 
assessed 
MM skills assessed   
Instruments Purpose* 
#
 item
s 
C
o
g
n
itiv
e 
P
h
y
sica
l 
S
en
so
ria
l 
Skills assessed  
S
co
rin
g
 
S
ca
le 
T
im
e 
(m
in
s)
# 
MMAA9 
To assess geriatric mental health patients 
ability to independently manage medications 
4 + + + 
1) recall information, 2) describe full regimen, 3) 
open/close, 4) remove the dose from vials, 5) 
differentiate tablet by color   
0-25 45-60 
HMS10 
To test older adults’ ability to understand and 
implement a routine prescription medication 
2 + +  
1) Read Rx labels, 2) comprehend medication 
regimen, 3) plan a schedule for meds regimen, 4) 
open & close vails, 5) remove dose from vials, 6) 
organize pillbox.   
0-11 15-30 
MAT11 
To aid in placement decisions regarding level 
of care bases on MMC 
10 + +  
1) read Rx labels, 2) comprehend medication 
regimen, 3) open & close vails, 4) remove dose from 
vials, 5) organize pillbox 
0-100 5-15 
MMPT12 
To identify visual, physical and cognitive 
barriers in MM in older adults 
5 + +  
1) Read Rx labels, 2) open vials, 3) interpret 
medication instruction, 4) calculate days’ supply  
0-5  
VRAMMA13 
To assess MM skills in patients with 
schizophrenia 
4 +   1) Read Rx label, 2) interpret medication instruction  
No 
specific 
 
ManageMed31 
To quickly determine if someone can handle 
a moderately difficult medication routine 
33 + +  
1) red Rx label, 2) recall information, 3) open/close 
vials, 4) perform calculations, 5) organize pillbox  
0-42 15-20 
S-532 
To screen the safety and readiness of self-
medication after stroke. 
16 + + + 
1) Read Rx labels, 2) recall information, 3) interpret 
med instruction, 4) open different vails, 5) 
differentiate tablets by shape, color, & size, 6) 
describing the administration process for injectable 
med (if required)  
Yes-no 4-6 
Performance-based instruments use both standardized & patient’s medication regimens 
MAI14  
To evaluate patients’ knowledge and skills to 
take medications and identify barriers to 
optimal MM 
2 + + + 
1) Read Rx & auxiliary labels, 2)open different vails, 
3) differentiate tablets by color, 4) name all meds, 5) 
state indication, 6) duration med should be taken, 7) 
state dose and time  
 
15 – 
30 
PA15 
To identify barriers to medication self-
administration and to assist discharge-
planning decisions in hospital 
28 + + + 
1) Read labels, 2) open vials, 3) remove dose from 
vials, 4) differentiate tables by color, 5) organize 
pillbox, 6) describe a regimen, & 7) swallow pills 
0-28 20 
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MM 
abilities 
assessed 
MM skills assessed   
Instruments Purpose* 
#
 item
s 
C
o
g
n
itiv
e 
P
h
y
sica
l 
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l 
Skills assessed  
S
co
rin
g
 
S
ca
le 
T
im
e 
(m
in
s)
# 
SMAT33,34 
To screen for MM deficits in older adults & 
facilitate targeted interventions 
44 + + + 
1) Read Rx labels, 2) recall information, 3) interpret 
medication instruction, 4) open vials, 5) remove 
tablets from packaging, 6) differentiate tablet by 
color, & 7) organize pillbox 
Multiple 
scale 
 
RAT35 
To assess elderly patients' needs for 
additional support in managing their 
medicines 
13 + +  
1) Read Rx labels, 2) open different medication 
packaging, 3) manipulate with 5 ml spoon and eye or 
ear drop bottles    
0-26 5-20 
Performance-based instruments use only pillbox  
Medi-Cog26 
To assess patients’ ability to fill their own 
prescribed medications 
into a pillbox  
3 +   
1) Read Rx labels, 2) interpret medication 
instructions, 3) organize pillbox  
0-10  
Pillbox Test27 
To asses a four compartment of Executive 
Function through the real-time assessment of 
MM 
5 + + + 
1) Read Rx labels, 2) interpret medication 
instruction, 3) open vails, 4) differentiate tables by 
color, 5) organize pillbox  
No 
specific 
 
MM = medication management, Meds = medications, DRUGS = Drug Regimen Unassisted Grading Scale, MedMaIDE = Medication Management Instrument for Deficiencies in the Elderly, HOME–
Rx = In-Home Medication Management Performance Evaluation, PillQ = Pill Questionnaire, MMEI = Medication Management Evaluation Instrument, SM Task = Standardized Medication Task, 
MM Test = Medication Management Test, RACT = Regimen Adherence Capability Test, MMT = Medication Management Test,  MMT-R = Medication Management Test-Revised, MMAA = 
Medication Management Ability Assessment, HMS = Hopkins Medication Schedule, MAT = Medication Administration Test, MMPT = Medication Management Performance Test,  VRAMMA = 
Virtual Reality Apartment Medication Management Assessment, S-5 = Self-Medication Safety Post-Stroke Scale (S-5), MAI = Medication Assessment Instruments, PA = Pharmacy Assessment, 
SMAT = Self-Medication Assessment Tool, RAT = Self-medication Risk Assessment Tool 
* Purpose stated as described by the developers  
# Reported administration time (minutes)
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Table 2.3 Studies that Introduced a Medication Management Assessment Instrument 
 Study description Validity Reliability 
Instruments 
(Authors, year) 
Design 
 
Aim Sample, n 
Age, 
years 
mean 
(SD) 
Content Construct^ 
Inter-
rater* 
Test-
retest* 
Internal 
consiste
ncy** 
Performance-based instruments use patients’ own medications 
DRUGS 
(Edelberg H.K., 
et al., 1999)  
(Edelberg H.K., 
et al., 2000) U.S. 
Cross-
sectional 
 
Prospective 
cohort   
To introduce DRUGS and examine 
the relationship between inability 
to take medications and cognitive 
impairment  
Outpatient 
older 
adults, 59 
84.20 
(5.1) 
+ 
Cognitive function  
(MMSE)  
Functional status 
(ADL & IADL) 
Self‐reported MMC 
Health literacy  
+ 
(>0.90) 
+ 
(>0.90) 
 
 MedTake (Raehl 
C.L., et al., 2002) 
U.S.  
Cross-
sectional 
To quantify how seniors' ability to 
take oral drugs safely may 
correlate with age, sex, 
socioeconomic status, education, 
cognitive impairment, depression, 
and drug self-management  
Outpatient 
older 
adults, 57 
79.49 
(7.26) 
+ 
Cognitive function  
(MMSE)  
Educational level   
   
MedMaIDE 
(Orwig D., et al., 
2006) U.S. 
Cross-
sectional 
To describe the MedMaIDE and to 
provide results of reliability and 
validity testing 
Outpatient 
older 
adults, 50 
78.18 
(7.21) 
+ 
Cognitive function  
(MMSE) 
Functional status 
(ADL) 
Med. adherence 
(pill count) 
+ 
(0.74) 
+ 
(0.93) 
+ 
(0.71) 
HOME-Rx 
(Bolduc JJ, et al., 
2015) 
(Murphy M.C., et 
al., 2017)  U.S.  
Cross-
sectional  
To develop a novel, 
performance-based medication 
adherence assessment, HOME–Rx 
Communit
y-dwelling 
older 
adults, 5 
Experts, 7 
75.6 
(4.4) 
+ 
Cognitive function 
(MoCA) 
MMC (MangeMed)   
   
Show Back 
(Kapoor A., et 
al., 2018) U.S.  
Cross-
sectional 
To develop a standardized 
simulation to assess MM 
proficiency in older adult by home 
nurses and test reliability  
Communit
y-dwelling 
older 
Adults, 10 
76 (7.1) +  + $   
Self-reported instruments use patients’ own medications 
PillQ (Kim J.S., 
et al., 2013) 
South Korea 
Cross-
sectional 
To evaluate the correlation 
between ability to MM and 
Outpatient  
with PD, 
208 
66.4 
(7.1) 
+ 
Cognitive function 
(MMES, MoCA, 
CDR)  
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cognitive functioning in patients 
with Parkinson’s disease 
Function status 
(ADL) 
 Study description Validity Reliability 
Instruments 
(Authors, year) 
Design 
 
Aim Sample, n 
Age, 
years 
mean 
(SD) 
Content Construct^ 
Inter-
rater* 
Test-
retest* 
Internal 
consiste
ncy** 
Performance-based instruments use standardized medication regimen 
Patient's barriers 
to compliance 
(Hurd P.D., et at., 
1986) U.S.  
Cross-
sectional 
To understand the patient's barriers 
to compliance 
Outpatient 
older 
adults, 14 
75.5 + Age     
MMEI (Meyer 
M.E., et al., 
1989) U.S.  
 
 
 
Cross-
sectional 
To develop a simple objective 
screening tool that assess the 
patient’s functional ability to take 
medications.    
In & 
outpatient 
older 
adults, 93  
74.3 
(10.1) 
+ 
Cognitive function 
(CCSE) 
   
SM Task (Isaac 
L.M., et al., 
1993) Canada   
Cross-
sectional 
To describe the development of a 
method for assessing the 
relationship between cognitive 
function, comprehension, and 
compliance with medication 
Outpatient 
older 
adults, 20  
71.5 
(5.8) 
+ 
Cognitive function 
(neuropsychologica
l battery)  
Function status 
(grip strength) 
Self-reported 
adherence  
   
MM Test 
(Gurland B.J., et 
al., 1994) U.S. 
Cross-
sectional 
To measure high-level adaptive 
cognitive functioning in early 
dementia 
Older 
adults, 259 
Range 
(65-85) 
+ 
Cognitive function 
(CARE) 
Dementia diagnosis   
  
+ 
(0.82) 
RACT (Fitten 
L.J., et al., 1995) 
U.S.  
Cross-
sectional 
To develop an instrument that will 
facilitate and focus the assessment 
of a patient's capacity to adhere to 
a medication regimen before its 
initiation 
In & 
outpatient 
older 
adults, 55 
69.95 
(7.46) 
+ 
Cognitive function 
(MMES) 
Different patients 
group  
+ 
(0.70) 
  
MMT (Albert 
S.M., et al., 1999) 
U.S.  
Cross-
sectional  
To examine the relationship 
between neuropsychological 
status, MMT, and antiviral 
medication adherence. 
HIV-
positive 
patients, 61 
42.25 + 
Cognitive function 
(neuropsychologica
l battery test)  
Self-reported 
adherence  
+ 
(≥0.72) 
 
+ 
(≥0.74) 
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 Study description Validity Reliability 
Instruments 
(Authors, year) 
Design 
 
Aim Sample, n 
Age, 
years 
mean 
(SD) 
Content Construct^ 
Inter-
rater* 
Test-
retest* 
Internal 
consiste
ncy** 
MMT-R (Heaton 
R.K., et al., 2004) 
U.S. 
Cross-
sectional 
To evaluate the impact of HIV-
associated NP impairment in HIV-
infected patients  
HIV-
positive 
patients, 
267 
39.32 
(7.52) 
+ 
Cognitive function 
(neuropsychologica
l battery test) 
Function status 
(IADL) 
 
+ 
(0.96) 
+ 
(0.72) 
MMAA 
(Patterson T.L., 
et al., 2002) U.S.  
Cross-
sectional 
To introduce MMAA, and 
compare its findings with 
adherence   
Healthy 
participant, 
33 vs. 
Schizophre
nic 
patients. 
104  
63.10 
(8.8) 
 
56.10 
(8.4) 
+ 
Cognitive function 
(neuropsychologica
l battery test) 
Adherence 
(Pharmacy data) 
  
+ 
(0.96) 
HMS (Carlson 
M.C., et al 2005) 
U.S. 
Cross-
sectional 
To develop HMS and validate it  
Outpatient  
females, 
360 
77.5 
(2.8) 
+ 
Cognitive function 
(MMSE)  
Functional status 
(IADL) 
  
+ 
(0.38) 
MAT (Schmidt 
K.S., et al., 2005) 
U.S.  
Cross-
sectional 
To examine the construct and 
concurrent validity of the MAT  
Communit
y-dwelling 
older 
adults, 62 
85.56 + 
Cognitive function 
(MMSE)  
Functional status 
(IADL) 
   
MMPT 
(Beckman G.K., 
et al., 2005) 
Sweden 
Cross-
sectional 
To uses performance tests of hand 
function, vision and medication 
competence to assess the 
limitations in these dimensions in a 
population-based sample of elderly 
people 
Communit
y-dwelling 
older 
adults, 492 
82.9 + Self-reported MM    
VRAMMA 
(Kurtz M.M., et 
al., 2007) U.S.  
Cross-
sectional 
To validate VRAMMA as a tool 
for measuring MM skill in patients 
with schizophrenia 
patients 
with 
schizophre
nia, 25 & 
healthy 
people, 18  
42.1 
(10.5) 
+ 
Cognitive function 
(neuropsychologica
l battery test) 
MMC (MMAA)  
   
ManageMed 
(Robnett R.H., et 
al., 2007) U.S. 
Cross-
sectional 
To introduce ManageMed and 
complete initial reliability and 
Outpatient 
older 
adults, 67 
76 
Range 
(47-95) 
+ 
Neurocognitive 
function 
(Cognistat) 
+ 
(0.86-
0.96) 
 
+ 
(0.89) 
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validity analyses on the 
ManageMed Screening  
Number of meds 
taken  
S-5 (Kaizer F., et 
al., 2010) Canada  
Cross-
sectional 
To develop and pilot 
test a S-5 to be used in screening 
for self-medication safety in 
individuals after stroke 
Patients 
with 
stroke, 6  
Range 
(50-70) 
+     
Performance-based instruments use both standardized and patient’s medication regimens 
MAI (Murray 
M.D., et al., 
1986) U.S. 
Cross-
sectional 
To examine the extent and 
correlates of noncompliance in 
community-dwelling older adults  
Outpatient 
older 
adults, 140  
71.59 
(9.81) 
+ 
Self-reported 
adherence  
   
PA (Romonko L., 
et al., 1992) 
Canada  
Cross-
sectional 
develop an PA to better 
identify drug and patient-specific 
concerns and to then  
compare it to 
nursing and medical assessments 
utilized in geriatric 
Hospital 
discharged 
patients, 51  
80.9 + 
Self-reported 
adherence  
Hospital self-
medicated program  
Medication-related 
problems  
   
SMAT (Irvine-
Meek J.M., et al., 
2011) Canada  
Cross-
sectional 
To evaluate the psychometric 
properties, as well as the usability, 
of the SMAT, an instrument 
designed to measure elderly 
patients’ ability to manage their 
medications 
Older 
adults 
patients, 
121  
81.5 
(7.3) 
+ 
Cognitive function 
(MMSE, CDT, 
CCT)  
Medication 
regimen 
complexity 
Self-reported 
adherence       
+ 
(≥0.79) 
+ 
(≥0.83) 
+ 
(≥ 0.81) 
RAT (Lubinga 
S.J., et al., 2011) 
U.K. 
Cross-
sectional 
To determine scale reliability and 
validate the instrument against 
community pharmacists' 
assessment of patients' ability to 
manage their medicines 
community 
dwelling 
elderly 
patients, 37 
Median
= 76 
(IQR=7
2, 82) 
+ 
Patient’s 
comprehension and 
dexterity of 
handling the 
medications  
  
+ 
(≥0.79) 
Performance-based instruments use pillbox 
Medi-Cog 
(Anderson K., 
2008) U.S.  
Cross-
sectional 
to evaluate the association between 
the MMSE, 
Mini-Cog, MTS, or Medi-Cog 
cognitive screens with 
patients’ ability to fill their own 
prescribed medications 
into a pillbox 
Hospital 
discharged 
patients, 62 
62.5 
(13.5) 
+ 
Cognitive function  
Correctly filled 
pills 
   
Pillbox Test 
(Zartman A.L., 
2013) U.S. 
Cross-
sectional 
To examine the construct validity 
of a new measure of EF, the 
Pillbox Test which is a real-time 
Patients 
with 
Alzheimer’
68.63 
(8.08) 
+ 
Executive 
Cognitive Function 
measures   
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assessment of medication 
management 
s Disease 
& 
dementia, 
40  
Healthy 
controlled 
group, 80 
DRUGS = Drug Regimen Unassisted Grading Scale, MedMaIDE = Medication Management Instrument for Deficiencies in the Elderly, MoCA = Montreal Assessment of Cognition, HOME-RX = In-
Home Medication Management Performance, CDR = Clinical Dementia Rating Scale, CARE= Comprehensive Assessment and Referral Interview. CCSE = Cognitive Capacity Screening 
Examination, CDT = Clock Drawing Test, CCT = Cognitive Competency Test , SM Task = Standardized Medication Task, MM Test = Medication Management Test, RACT = Regimen Adherence 
Capability Test, MMT = Medication Management Test, MMT-R = Medication Management Test-Revised, MMAA = Medication Management Ability Assessment, PA = Pharmacy Assessment, HMS 
= Hopkins Medication Schedule, MAT = Medication Administration Test, MMPT = Medication Management Performance Test,  VRAMMA = Virtual Reality Apartment Medication Management 
Assessment, S-5 = Self-Medication Safety Post-Stroke Scale, MAI = Medication Assessment Instruments, SMAT = Self-Medication Assessment Tool, RAT = Self-medication Risk Assessment Tool, 
MTS = MedicationTransfer Screen 
* Reliability coefficient  
** Alpha coefficient   
^ Significant correlation or association  
$ Interrater agreement was reported as κ values for identification (κ = 0.220, 95% CI = −0.142-0.584), explanation (κ = 0.837, 95% CI = 0.627-1.046), organization (κ = 0.840, 95% CI = 0.442 -
1.229), administration (κ = 0.633, 95% CI = 0.232-1.034), and timing (κ = 0.702, 95% CI = 0.409-0.997)  
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Table 2.4 Characteristics for Instruments Assessing Medication Management Capacity 
 
Using patients’ own 
medications 
Using standardized medication regimen 
Using both 
patient’s own 
medications and 
a standardized 
regimen 
Using 
pillbox 
Characteristics  
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M
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illb
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x
 T
est 
Assess cognitive & physical abilities  X X X X X  X X X X X X X X X X X  X X X X X X  X 
Cognitive MM skills 
Identify medications * /Or Read a 
standard med. label 
X X X X X X X X X X X X X X X X X X X X X X X X X X 
State indications  X X X X X    X           X  X    
Describe dosing time  X X X X X X X   X X   X X X     X X X    
Describe instructions on label   X X X X X X X X X X X X X X X X X X X X X X    
Know how to get refills    X                        
Refill pillbox $     X    X   X X  X X   X   X X  X X 
Physical MM skills  
Open medication packaging  X X X X   X X X X X X X X X X X  X X X X X X  X 
Remove tablets  X X X X      X X X X X X X   X   X X X  X 
Split tablets $     X    X                  
Administer non-oral drug ^    X X X               X    X   
Other characteristics  
Brief § X  X X X  X X X X  X X X X X   X X X X  X X  
Small & Portable   X X X X X X                   X  
Objective X X X X X X  X  X  X X X X X X X X X X X X X X X 
More than self-reported  X X X X X  X X X X X X X X X X X X X X X X X X X X 
Uncomplicated scoring system    X X X X X X  X  X  X X X X X X  X X  X  X X  
Less overwhelming or threatening  X X X X X X                     
Reliable ¥ X  X                    X    
Valid £ X X X X  X  X X X X X X X X X X X X  X X X X X X 
Sensitive to change in function over 
time  
X              X            
Guide future intervention  X X X X X X X X X X X X X X X X X X X X X X X X X X 
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* Identify medications by any means such as recalling medication name, distinguishing the appearance, or reading the label      $ If required or relevant                    
^ Such as, measuring a dose of liquid medication, administering injectable medications, and using inhalers devices                     £ Having some sort of construct testing beside simple content validity 
¥ Having complete and acceptable reliability evidence including inter-rater, test-retest reliability and/or internal consistency  
§ Reported administration time ≤ 30 minutes 
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 CHAPTER THREE 
SPECIFIC AIMS AND SIGNIFICNE 
3.1 Hypotheses and Specific Aims 
The overall goal of this line of research is to identify older adults living independently in 
low-income senior housing who are at risk of losing independence due to medication 
mismanagement by screening for medication self-management deficits. This will be achieved by 
addressing the following specific aims: 
Specific Aim One: To determine the cognitive and physical deficiencies in MMC among older 
adults who live in low-income housing.  
Hypothesis: A substantial number of older adults who live in low-income housing will have 
significant cognitive and physical functional deficiencies in their MMC (low capacity to manage 
their medication).  
Specific Aim Two: To identify variables that predict low MMC among older adults who live in 
low- income housing. 
2.1) Assess the relationship between MMC and demographic characteristics.  
2.2) Assess the association between MMC and the number of medications and doses that 
are taken per day and medication-taking behavior.  
2.3) Assess the association between MMC and comorbidities. 
2.4) Assess the association between MMC and health literacy, cognitive and functional 
status, and depression symptoms.  
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Hypothesis: Lower MMC in older adults is associated with increased number of medications and 
doses taken daily, increased number of medical conditions, declined in cognitive and functional 
status, lower health literacy, and having depression. 
Specific Aim Three: To determine the impact of using medication aids and specialized pharmacy 
services on MMC, with aids including medication cards/lists, organizers and reminders, and using 
specialized medication packaging, easy-to-open containers, large-print labels, medication 
synchronization, or prescription home delivery service.  
Hypothesis: Using at least one specialized pharmaceutical service will increase the MM score. 
Specific Aim Four: To determine the association between MMC and ER utilization over the past 
six months in this population.  
Hypothesis: Older adults with low MMC will be at a higher risk of using the ER.  
3.2 Significance  
Living in a low-income community with age-related decline in cognitive and functional 
ability coupled with multiple comorbidities increases the demand for community-based long-term 
services and support (LTSS). LTSS provides assistance with daily self-care tasks such as eating, 
bathing, dressing, managing medication, and preparing meals. It is estimated that 70% of older 
adults will need LTSS at some point in their life.1 Problems related to medication mismanagement 
are costly and may lead to serious complications such as hospitalization and institutionalization.2,3 
In fact, a study on the causes of hospitalization among community-dwelling older adults confirmed 
that the risk of hospital and long-term care admissions increased with lack of assistance when 
medication support was needed.4 Moreover, the U.S. healthcare system could save as much as $2.6 
billion by retaining community-dwelling older adults to age in their homes instead of transferring 
them to long-term care facilities.5 
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Therefore, understanding the challenges that low-income older adults face during routine 
management of medications may help identify targets for future intervention to ensure safe 
medication use. This indirectly will promote healthy aging in place and independence in this 
population. Consequently, healthcare utilization and the strain on community-based LTSS might 
be reduced as well.  
This study seeks to identify factors among independently-living low-income older adults 
that may predict deficiencies with medication self-management, which could guide future 
interventions. First, by exploring the relationship between MMC and various factors, we will help 
identify individuals who are at risk for medication mismanagement. Second, determining cognitive 
and physical deficiencies in medication management could help healthcare providers (e.g. 
pharmacists) identify key targets for intervention strategies based on the individual’s need, to 
enhance medication use. For example, providing counseling sessions for older adults who have 
limited knowledge about their medications or ordering non-child resistant or specialized packaging 
for those who have difficulty opening the bottles of their medication. 
In summary, this study seeks to determine the medication self-management capacity 
among low-income older adults. In addition, it identifies risk factors that may predict deficiency 
in medication self-management capacity among this population, which helps to guide intervention 
based on their needs. This study will add evidence for the utility of using a standardized tool to 
assess MMC in outpatient settings and ultimately guide interventions to help older adult people to 
maintain their independence in their home. 
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CHAPTER FOUR  
METHODS 
4.1 Study Design  
This is an observational, cross-sectional study. The study data was collected during a semi-
structured interview using a battery of assessments. These assessments were selected based upon 
the reliability and validity data supporting use in outpatient settings as well as the time required to 
be administered. The recruitment, eligibility screening and interviewing was performed by the 
study investigator (Amal Badawoud).  All assessments were performed by the study investigator 
during a scheduled, face-to-face interview with each eligible participant. . The participants were 
asked to bring all of their current medication containers (i.e. all medications that they use regularly) 
to the interview, including prescription and over-the-counter (OTC) medications, vitamins and 
minerals, and dietary supplements (anything they used on a regular basis). 
4.2 Study Setting and Participants  
This study was conducted in five low-income apartment buildings that are served by the 
community-based Richmond Health and Wellness Program (RHWP). These buildings are 
designated for low-income people who are aged 55 years and older or individuals with disabilities. 
They are located in downtown Richmond, Virginia, and are considered as healthcare “hot spot” 
areas where the population lives with a high burden of chronic illnesses, and increased healthcare 
utilization such as unnecessary emergency room (ER) visits and ambulance use. Therefore, the 
overall goal of RHWP is to reduce unnecessary health care utilization through health and wellness 
promotion. It is designed to provide care coordination services to residents, as well as education, 
training, and research opportunities for healthcare students. For example, RHWP clinics provide 
medication management, geriatric assessments, follow-up and communication with primary care 
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providers, and blood pressure and glucose monitoring.1 RHWP is based on a patient-centered care 
principle, where residents’ needs determine the care and support provided by an interprofessional 
team. The team consists of three to four students ─ from the VCU Schools of Nursing, Pharmacy, 
Medicine, Social Work, and the Department of Psychology ─ who are overseen by licensed clinical 
faculty. The main goal is to improve residents’ health outcomes, experience with the healthcare 
system, and quality of life in order to decrease healthcare costs. At the same time, this practice 
also improves students’ performance.1  
Approximately 247 residents live in Building 1, 137 live in Building 2, 105 residents live 
in Building 3, 77 live in Building 4, and 55 live in Building 5. A total of 348 residents were enrolled 
in RHWP from September 2012 through December 2016. The majority of RHWP enrollees are 
female (58%), African-American (72%), and with an average age of 74 years. Half of the enrollees 
have two or more chronic diseases. Most residents (84.5%) live independently (i.e. do not have 
help/aid in the home), and approximately 65% are unable to drive. Most of them use assistive 
devices, approximately 36% use a cane, 28% use walker, and 7% are in a wheelchair.1,2 
Reviewing residents’ medications is an important service provided by the RHWP. The 
most frequent interventions were individualized medication counseling (52%), and medication 
management (24.7%).2 Most of RHWP enrollees (90%) are responsible for managing their 
medication independently, and approximately 80% of enrollees are responsible for ordering their 
medication refills. About 45% of them brought their medications to the RHWP clinics for review. 
Residents reported some medication-related issues including having difficulty reading prescription 
labels (18%), opening prescription bottles (16%), paying for medications (11%), and getting refills 
on time (12%).  
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Inclusion and Exclusion Criteria:  
Residents living in buildings served by RHWP were recruited for this study based upon the 
following criteria: those who were: 1) living in one of the five apartments buildings served by 
RHWP, 2) aged 55 years or older, 3) currently taking at least one prescription or over-the-counter 
(OTC) medication, 4) living independently, 5) not relying on another person to administer 
medications (i.e. family members, friends, or caregivers), 6) able to read and converse in English, 
7) not diagnosed with Alzheimer’s disease or dementia, and 8) not taking any medications for 
memory such as cholinesterase inhibitors and memantine (i.e. inferred diagnosis of dementia).  
Exclusion criteria included participants who were: 1) less than 55 years old, 2) not taking 
at least one prescription or OTC medication on a regular basis, 3) fully relying on a caregiver to 
administer medications, 4) not able to communicate in English, or 5) reported having a diagnosis 
of Alzheimer’s disease or dementia or taking any medication for memory.  For example: any 
participants taking cholinesterase inhibitors which include donepezil (Aricept®), rivastigmine 
(Exelon®), galantamine (Razadyne®, Razadyne ER®); memantine  which include  (Namenda®, 
Namenda Titration Pak®, Namenda XR®, or Namenda XR Titration Pack®); or taking combination 
of memantine and Donepezil (Namzaric®) were excluded. The Screening for Eligibility form is in 
Appendix 1. 
4.3 Recruitment Strategy & Screening for Eligibility   
The ideal sampling strategy would be a random selection of residents living in subsidized 
housing communities under HUD. However, it would be difficult to access HUD data due to 
ethical consideration and privacy concerns and policies to protect privacy, especially for the 
vulnerable older adult population. In addition, using this sampling stratgy would be very expensive 
and it might take a longer time for recrutiment.  
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Therefore, a nonprobability (non-random) sampling strategy, primarily a convenience 
sampling technique, was used to recruit the study participants. Convenience sampling is a type of 
nonprobability sampling where the target population meets certain predefined criteria, such as easy 
accessibility, availability at a specific period of time, or willingness to participate. In other words, 
the convenience sample is the population who is easily accessible to the researcher.3 This sampling 
technique is convenient, easy, and affordable. Typically, the convenience sample is homogeneous 
because they are recruited from one target population. However, the main disadvantage of this 
sampling technique is limited generalizability; the results may not be representative of the entire 
population.   
Furthermore, a snowball sampling technique was used where the study participants were 
asked to encourage other people to participate in the study. During the recruitment phase, those 
participants who completed the study interview referred their friends and neighbors in the 
buildings to participate in the study.  Using this sampling technique helps to accelerate the 
recruitment process within a short period of time. Like convenience sampling, this sampling 
technique may lead to limited generalizability and selection bias.3Several recruitment methods 
were used in this study including 1) posting flyers around the apartment buildings and RHWP 
clinics, 2) distributing the brochure to residents in all buildings, and 3) introducing the study to 
residents during group education sessions given by RHWP providers. The study flyer and brochure 
included a brief description of the study and inclusion criteria and contact information for study 
investigators. The study recruitment flyer and brochure are in Appendix 2.  
In order to partner with the housing buildings and gaining permission to post the study's 
flyers and distribute brochures, the study investigators shared the information about the study with 
the resident services coordinators at each building. In addition, the study investigators met with 
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RHWP clinic staff and discussed the study aims and methods with them to ensure that the conduct 
of the study was not disruptive to clinic operations but rather was complementary to the clinic.  
These are some of the important factors in successfully carrying out community-based research—
getting buy-in from multiple stakeholders to drive success. 
The study investigator was responsible for answering any questions about the study from 
the residents who were interested in participating in the study. The contact information of the 
investigator was given to the residents who had questions or wanted more information about the 
study. After getting all their questions about the study answered, participants signed the screening 
consent form.  All residents who were interested in the study were screened for eligibility based 
on the inclusion criteria.  To see if they were eligible to be in this study, they were asked about 
their age, medication history, whether they were living independently, able to manage their 
medication with no assistance, and whether they had been diagnosed with Alzheimer’s disease, 
dementia or memory problems. This screening interview took approximately five minutes or less.  
Potential study participants had the option to complete this screening process over the phone or in-
person. Both in person and telephone screening consent forms were developed by the investigator 
and approved by the VCU Institutional Review Board. The screening consent form included a brief 
description of the study, its purpose, voluntary participation, risks and benefits, confidentiality 
protections, and HIPAA authorization, as well as the contact information for the study PI. The in-
person and telephone screening consent forms are in Appendix 3.  
After screening for eligibility, the individual interview was scheduled by the investigator for each 
eligible participant. Eligible participants were asked to bring their current medication containers 
(i.e. all medications that they use regularly), including prescription and OTC medications, and 
vitamins and minerals. In addition, the investigator conducted a day-before reminder phone call 
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with eligible participants who provided their phone number.  The script for the phone call 
reminder/message is in Appendix 4. 
4.4 Interview Procedure 
The investigator was available in the community area at each resident building during 
RHWP clinic hours.  Many candidate participants came to the clinic with their medication, ready 
for the individual study interview. In this case, the investigator started the interview screening for 
eligibility and then proceeded with the study interview. Typically, the study interview procedure 
took about 30 to 45 minutes, and not more than 60 minutes. All study interviews took place in a 
private area during RHWP clinic hours. At the beginning of the interview, the investigator 
completed a Research Subject Information and Consent Form with each eligible participant. The 
Research Subject Information and Consent Form is in Appendix 5. Before asking the participant 
to provide their signature on the informed consent form, the investigator went over each section in 
the consent form with the participants and answered any remaining questions. The informed 
consent form was developed by the study investigator. It included detailed information about the 
study, its purpose and process, risk and discomfort, benefits, cost and payment process, 
confidentiality, voluntary participation and withdrawal, and HIPAA authorization. In addition, it 
included the full contact information for the study PI and the office of research at VCU.  It was 
approved by the VCU IRB. A copy of the full informed consent form was provided for all 
participants as a reference for them.  
After completing the consent process, the demographic information and medical history were 
collected. The participant was then asked to display all medication containers they brought with 
them and the investigator gathered all relevant information (see section 4.2 medication list). Using 
the complete and comprehensive list of medication taken, a participants’ medication self-
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management capacity was assessed using the Medication Management Instrument for Deficiencies 
in the Elderly (MedMaIDE) Tool.6 Following the MMC assessment, participants were asked 
questions related to their medication-taking behavior, using medication aids, ordering pharmacy 
services, and ER utilization in the last six months. Following that, additional assessments were 
administered with the following order: health literacy, cognitive function, functional status, and 
depression symptoms. Upon completing all assessments, each participant received $15 cash as 
compensation for their time. 
4.5 Study Measures 
Demographic Characteristics: Each participant was asked about his/her age, sex (male and 
female), race (Caucasian, African-American or Black, Hispanic, and Other), marital status (single, 
married, separated, divorced, and widowed), educational level (less than high school diploma, high 
school graduate/GED, some college, college degree completed), and type of insurance (Medicaid, 
Medicare, Dual Eligible, Veteran, other). In addition, the participants were asked to report their 
living arrangement (alone, or with other people), as well as how they would rate their health status 
in general (excellent, very good, good, fair, poor).  
Medical History: The number of comorbidities was recorded using the Functional Comorbidity 
Index (FCI). It is a list of 18 clinical comorbidities validated for adjusting the impact of 
comorbidity on physical functional status. Participants were asked if they had any of the 18 medical 
conditions included in the FCI: arthritis, osteoporosis, asthma, chronic obstructive pulmonary 
disease (COPD) (or acquired respiratory distress syndrome (ARDS) or emphysema), angina, 
congestive heart failure (or heart disease), heart attack (or myocardial infarction), neurological 
disease (e.g., multiple sclerosis or Parkinson’s disease), stroke (or transient ischemic attack (TIA)), 
peripheral vascular disease,  diabetes types I and II, upper gastrointestinal disease (e.g., ulcer, 
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hernia, reflux), depression, anxiety or panic disorders, visual impairment (e.g., cataracts, 
glaucoma, macular degeneration), hearing impairment (i.e., very hard of hearing even with hearing 
aids), degenerative disc disease (e.g., back disease, spinal stenosis, or severe chronic back pain), 
or obesity and/or body mass index (BMI) > 30. The weight in pounds and height in inches were 
collected to calculate the BMI. Each listed medical condition is given one point if present and the 
final score for the FCI is the sum of all present conditions, which ranges from 0 to 18.4 
Medication List: A medication list was created for all medications that were brought by the 
participant to the study interview. In the list, the investigator recorded information about each 
medication including name (brand or generic), strength, dosage form, dose, the route of 
administration, and frequency based upon the label on the medication bottle. The dose and 
frequency were not recorded for those prescription medications with a lost or unreadable label. A 
total number of medications was calculated as the absolute total count of medications brought by 
the participant during the study visit, including prescription and OTC medications, 
vitamins/minerals, and dietary supplements as well as as-needed medications (PRN). The number 
of daily doses was the count of total doses for these medications except for the PRN medications 
doses.  For example, two tablets three times per day counted as three doses, regardless of the 
number of tablets taken for one medication dose. 
Medication Regimen Complexity: The information collected in the medication list was used to 
calculate the complexity of the medication regimen for each participant using the Medication 
Regimen Complexity Index (MRCI) tool.5 MRCI was selected because it has been widely used in 
research studies and validated among older adult patients. It is a reliable and valid tool designed 
to quantify the complexity of the prescribed medication regimen based upon the dosage form, 
dosing frequency, and the additional administration directions for each medication in the regimen. 
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It includes 65 criteria divided into three sections, and each item is assigned a weighted score 
corresponding to the relative degree of complexity it adds to the regimen. The first section includes 
the weighting score for different dosage forms (e.g. oral: capsules/tablets, liquids, sublingual 
sprays/tablets; topical: creams/gels/ointments, patches). The second section represents the 
weighting score corresponding to the dosing frequency for each medication in the regimen. The 
third section indicates the additional directions if present for each medication. The total MRCI 
score is the sum of the scores of the three sections. Since the total MRCI score is based upon how 
many prescription medications have been taken by the patient, the minimum total score could be 
0 while there is no maximum score.5 In this study, MRC was assessed for only the prescribed 
(scheduled and PRN) medications.  
Medication Self-Management Capacity (MMC): The Medication Management Instrument for 
Deficiencies in the Elderly (MedMaIDE) was used to assess the participants' MMC. It was selected 
based upon a comprehensive review conducted to identify the suitable, published MMC 
instruments that designed to assess both cognitive and physical ability of older adults to manage 
their medications independently. It was the instrument that demonstrates the most promise to be 
used in this study. It is a standardized performance-based instrument and has been validated in 
outpatient settings. It is the most comprehensive instrument compared to other identified 
instruments; the items included in MedMaIDE consolidate the required tasks associated with 
managing prescription medication and encompass all six steps of the model of medication self-
management. It is the only instrument that determines patient’s knowledge of how to get their 
medications, and is not limited to oral medications. In addition, it is short and quick, it takes 
approximately 30 minutes to administer.6  
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It was developed by a panel of experts in gerontology at the University of Maryland. Previous 
research has shown that MedMaIDE is a reliable [test-retest reliability (CC= 0.93), interrater 
reliability (CC= 0.74), and internal consistency (Cronbach’s alpha = 0.71)] and valid instrument 
for identifying cognitive and functional deficiencies in managing medications among older adults 
in home settings using their own medications.6,7  The assessment procedure is based upon 
observing the medication-taking ability and assessing the knowledge about the individual’s own 
medications. It includes 20 items covering three important areas of medication self-management: 
1) medication knowledge, 2) medication-taking ability, and 3) knowledge about the ongoing 
supply of medications. This medication knowledge was assessed by asking the person to name all 
medications; state when, how, why, and the amount of each medication that should be taken, and 
whether he/she can identify any problems after taking the medication. The functional ability was 
assessed by asking whether the person is able to fill a glass and sip enough of water to swallow 
the pills per dosage and asking them to demonstrate opening medication bottles and counting out 
the required number of pills, and asking them how they are supposed to administer their 
medications (e.g. pointing to the mouth for inhalers and pills, or describing how to draw up 
insulin). The third area assesses whether the person is able to obtain his/her medication and sustain 
the use of medications by asking about the existing refills, who to contact to get a new prescription, 
and whether or not they have the resources to obtain medications (like transportation).6 
Each item scores as 0 (able) or 1 (unable), however, only 13 of the 20 items are scored (Table 
4.1). The participant must be able to answer each question correctly for all medications to receive 
a score of able = 0. The total deficiency score is the sum of the three deficiency sub-scores. The 
maximum total score is 13, with a higher score indicating less ability for medication self-
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management. 6 The non-scored items give more details to determine the overall ability to manage 
medication and identify the appropriate intervention to enhance medication use.  
Table 4.1 Medication Management Instrument for Deficiencies in the Elderly (MedMaIDE) 
Areas 
Number of 
items 
Number of 
scored items 
Range of the 
scored items 
First: Medication knowledge 8 5 0 – 5 
Second: Medication-taking 
ability 
6 5 0 – 5 
Third: Access to ongoing supply 6 3 0 – 3 
Total deficiency score  20 13 0 – 13 
After completing the medication list, the participants’ medication bottles were kept 
displayed on the table in front of the participant. The lists of active medications and the labels on 
the containers were used as a reference for what was reported by the participant.  Lexicomp Online 
was used as a reference to confirm the indication for any new or unfamiliar medications by the 
investigator. Moreover, the participants were encouraged to use their medication bottles any time 
to answer any question.  The scored questions in the first section were asked for each medication 
that was brought to the visit by the patient, including scheduled and non-scheduled medications. 
In the second section, if more than one medication was taken, the participant was asked to count 
the required number of pills for only one medication, and open the bottle cap for different vial 
sizes or different packaging used by the participants. In the third section, the participant was asked 
to identify the existing refills for one or two medications and whether they could identify the name 
of the pharmacy, physician, or senior medical center from which they receive their medications.  
Medication-Taking Behavior: The participants were asked questions related to their medication-
taking behavior. First, the participants were asked whether they have medication adherence 
barriers. They were asked to report whether they had trouble reading the prescription labels, 
opening any medication bottles, refilling or getting the medication on time, or paying for their 
medications.  
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Medication nonadherence was assessed using the Self-Rating Scale Item (SRSI). It was 
chosen because it is a single item, self-reported medication adherence measure and it is easy to be 
administered in outpatient clinical settings.  This single question is “thinking about the past four 
weeks, please rate your ability to take your medications as prescribed,” using a five-point Likert 
scale (Excellent, Very Good, Good, Fair, Poor). This single item measure has been validated 
among HIV-infected patients, and has shown a significant positive correlation with other objective 
adherence measures. In the validation study, patients who rated their ability as excellent were 
considered adherent while all other responses were considered non-adherent. This measure has 
been validated using the  medication event monitoring system (MEMS) with excellent responses 
representing a mean of about 80% adherence on MEMS.8,9  
Receiving Assistance with Medications: The participants were asked whether they had someone 
reminding them to take their medication, setting up their medications in advance (i.e. setting up a 
pillbox), or ordering the refills for them on a regular basis. They were categorized into groups: 
receiving assistance and not receiving any assistance.  
Pharmaceutical Aids/Services: Participants were asked whether they use any medication aids, 
such as a medication list or card, medication organizers (e.g. pill box) or reminders (e.g. calendar, 
phone application). Moreover, they were questioned about using any services that  are provided 
by a pharmacy to help them to take or manage their medication, such as ordering specialized 
medication packaging (e.g. bubble packs or unit dose packaging, easy to open containers, large 
print label), or using medication synchronization, prescription home delivery or mail order 
services. Study participants were categorized into three groups: 1) not using any specialized 
services, 2) using one service, and 3) using two or more services. 
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Emergency Room Utilization: ER visits were assessed retrospectively over the past six months. 
Participants were asked whether they had been in the ER in the last six months, and if yes, how 
often. Moreover, the main reason for the ER visit was recorded (medical/health-related problems, 
fall-related problems, medication-related problems, or other). Participants were dichotomized into 
two groups: not reporting any ER visit, and reporting any ER visit.  
Health Literacy: Health literacy was assessed using three brief screening questions. These 
questions have been validated to identify patients with limited and adequate health literacy skills. 
These questions are 1) how often do you have someone help you read hospital materials? 2) how 
often do you have problems learning about your medical condition because of difficulty reading 
hospital materials? and 3) how confident are you filling out forms by yourself? 
Each question is scored on a five-point Likert scale. The scale for the first and second 
questions is Never, Occasionally, Sometimes, Often, and Always. While the scale for the third 
question is extremely, Quite a bit, Somewhat, A little bit, Not at all.  The maximum total score is 
15 and higher scores indicate lower health literacy. Based on prior studies, any participant 
reporting a three or greater (i.e. sometimes or somewhat and greater) on any question, was scored 
as having inadequate or low health literacy. 10,11 These three questions were suitable to be used in 
this study because they were brief and quick, it took less than three minutes, and easy scoring 
system.     
Cognitive Status: Participants’ cognitive status was assessed using the Mini-Cog tool.12,13  The 
Mini-Cog is a quick, validated tool for screening for cognitive deficits in older adults in community 
settings. In addition, it has been used in the RHWP clinics to assess residents’ cognitive function. 
It is commonly used by pharmacists as screening of dementia within assisted living, long-term 
care, and community settings.12  It includes two components: a three-item recall and a clock-draw 
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task. During three-item recall, the investigator named three unrelated objects (e.g. village, kitchen, 
and baby) and asked the participant to recall them after completing the clock-draw task. For the 
clock-draw task, participants were asked to draw the face of a clock, then the hands of the clock 
pointing to 10 past 11:00. The maximum score for the Mini-cog is 5 points; one point for each 
word recalled correctly and two points for a normal clock drawing. A score of  ≥  three represents 
participants with unimpaired cognitive function while a score of ≤  two represents participants with 
impaired cognitive function.12,13, 14  
 Functional Status: Functional status was assessed using the Katz Activities of Daily Living 
(ADL) Index. It is commonly used in research studies as well as one of the clinical assessments 
used in RHWP clinics.  The ADL Index is a well-known tool used to evaluate participants’ ability 
to perform daily living activities independently, including bathing, dressing, toileting, transferring, 
continence, and feeding. Participants responded Yes (independent) or No (dependent) for each one 
of the six functions. A score of 6-5 will be reported as full function, 4-3 as moderate impairment, 
and ≤ 2 as severe functional impairment.15, 14 Moreover, participants were asked whether they use 
assistive devices or wear eyeglasses.  
Depression Symptoms: The Geriatric Depression Scale-15 (GDS-15) was used to assess how the 
participants felt over the past week. It is a 15-item questionnaire that has been validated in 
community settings for screening for symptoms of depression. All questions are in Yes and No 
format. A score of 0 to 5 was recorded as normal (no indication of depression) while a score of > 
5 indicated depression — which is consistent with previous literature.14 It was selected because it 
is short and easy to be administered with easy scoring system as well as it is one of the assessment 
tools that used in RHWP clinics. 
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4.6 Ethical Consideration  
In this study, participants were placed at greater than minimal risk due to the nature of data 
collected during the study interview. An expedited review was requested from the Institutional 
Review Board (IRB) at Virginia Commonwealth University (VCU). The IRB has approved the 
protocol of this study as an expedited study. Furthermore, all study materials including recruitment 
brochure and flyer, screening and full informed consent forms, and script for all study measures 
were reviewed and approved by the IRB. All participants signed the informed consent form that 
includes details about the study and clearly states that participation is voluntary. It also identifies 
the study investigator and the study PI. All interviews were conducted in the RHWP clinics in an 
assigned private area.  
According to the study protocol that has been approved by the IRB, all completed interview 
and assessments forms were recorded by ID number, not the participants’ names. The hard copy 
of the participants’ data including consent forms, demographics, medical, and medications data 
was kept in closed boxes in a secure place with the study PI (Dr. Patricia Slattum) at the VCU 
office. All participants’ data was entered into the Research Electronic Data Capture application 
(REDCap).   It is a secure web application, used to build and manage surveys and databases for 
research, and applicable to store any type of data.16 The findings for this study may be presented 
at meetings or published in papers, but participants’ identifying information will not be disclosed. 
Identifiers were removed from the dataset built in this study, and de-identified data may be used 
for other research studies by this study team or another researcher. 
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4.7 Statistical Analyses  
Descriptive statistics including mean and standard deviation, or frequency and percentage, 
where appropriate for all variables are described in the “Study Measures” section. All statistical 
analyses were performed using SAS statistical software (version 9.4, SAS Institute, Cary, NC) 
with a significance level of 0.05 and two-tailed tests.  
Specific Aim One: Descriptive analysis was performed to determine the cognitive and functional 
deficiencies in MMC. The total MedMaIDE deficiency score represents the overall deficiency in 
MMC for each participant. The first and third areas represent cognitive deficiency while the second 
area assesses the functional deficiency in MMC.  First, normality for the MedMaIDE sub-scores 
for each area and total deficiency score was checked. They were approximately normally 
distributed on the histograms. Therefore, the mean and ± standard deviation of MedMaIDE sub-
scores and total score were reported.  
Specific Aims Two: Linear regression analyses were conducted to identify variables that are 
associated with deficient/low MMC. The MedMaIDE total deficiency score was the outcome 
variable and used as continuous. The association between the total deficiency score and all study 
variables including demographics, comorbidities, medication-taking behavior, as well as geriatric 
assessments variables were tested. To compare the mean total deficiency score with continuous 
variables, Pearson’ correlation was used. For categorical variables, two-sample T-test with 
dichotomous variables and one-way ANOVA with multi-level variables were used. Re-
categorizing was performed for some variables to overcome small cell size and unequal variance 
issues. Race was re-categorized into white and nonwhite, marital status into never and ever 
married, living arrangement into living alone and with another, and health status into 
excellent/very good, good, and fair/poor. Moreover, the participants who rated their ability to take 
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their medications as prescribed as excellent were recorded as adherent while all other responses 
(very good, good, fair, and poor) were recorded as non-adherent.  The Pearson’s correlation 
coefficient (CC), mean and standard deviation (±SD) with p-value were reported. The mean 
difference and 95% confidence interval (CI) were reported for the significant associations.  
Linear regression analyses were performed to identify the significant predictors that were 
associated with low MedMaIDE total deficiency score. First, all variables were tested using 
bivariate linear regression analyses (unadjusted models). These bivariate analyses have been 
conducted to check the linear regression model assumptions and build the final adjusted model. 
Linear regression assumptions are: 1) all observations are independent, 2) the outcome and the 
predictors have a linear relationship (linearity), 3) the residuals have a normal distribution 
(normality), and 4) equal variance for all observations (homoscedasticity). Violation of model 
assumptions was corrected with transformation or recategorization. Collinearity was checked for 
all predicted and outcome variables, and any variable with a high correlation coefficient of 0.8 was 
eliminated.  Second, all predictor variables were used to build the multiple linear regression model 
(adjusted model). The adjusted models were created using backward selection technique with a p-
to-stay value of 0.25 or less. The backward elimination was began with the least significant 
predictor, and the variables were removed one at the time.  
Four separate models were created using the technique described. The first model tested 
the outcome with demographic characteristics and the second model included the comorbidities. 
The third one examined the medication-related variables including number of medications and 
daily doses that were taken, medication complexity, and medication-taking behavior. The last one 
included the variables for geriatric assessments such as health literacy, cognitive and functional 
status, fall, use of assistive devices, and depression symptoms.  After completing the four models, 
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the significant variables were entered into one model. The parameter estimates, standard errors 
(±SE), and p-value were reported for both unadjusted and adjusted models.  
Specific Aim Three: Linear regression analyses were conducted to determine the impact of 
receiving assistance with medication from someone and using pharmaceutical aids/services on 
MMC. The outcome variable was MedMaIDE total deficiency score while receiving assistance 
with medications and using medication aids/services were the main explanatory variables. The 
variable of receiving assistance with medications from someone was dichotomous (yes or no), 
while using pharmaceutical aids/services was three groups (using none, using one, using more than 
one).   
The association between the total deficiency score and these two variables, were checked 
using two-sample t-test and one-way ANOVA. The bivariate models were performed to assess the 
linear relationship between these two variables and the MedMaIDE total deficiency score. A 
Multiple linear regression model was conducted using all the potential predictors from specific 
aim two.  Using the same technique used in analyzing specific aim two, the model assumptions 
and collinearity were checked. Moreover, the backward selection model was used to build the final 
model. The main explanatory variables were kept in all final adjusted model regardless of their 
significance (p-value).  
Specific Aim Four: The purpose of this analysis was to determine the association between MMC 
and ER utilization over the past six months. The dichotomous ER visits variable was the outcome 
variable while continuous MedMaIDE total deficiency score was the main explanatory variable. 
A descriptive table was created including all study variables, stratified by ER visit groups (not 
reporting any ER visit and reporting one or more ER visits). The difference between the two ER 
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visit groups was assessed using the Chi-square test or Fisher's exact test when the cell size is small 
(≤ 5) for the categorical variables. A two-sample T-test was used for continuous variables.  
The association between ER utilization over the last six months (outcome) and MMC was 
examined using logistic regression analyses. Univariate logistic regression analysis was performed 
to determine the association between the ER visit groups and MedMaIDE deficiency scores, as 
well as other potential predictors for ER visits. The logistic regression assumptions were tested 
before conducting the adjusted logistic model. The logistic regression assumptions are: 1) the 
outcome is a binomial distribution, 2) the mean of the outcome is given by the logistic function 
which means continuous variables are equivalent, and all predictors are related to the log odds of 
the outcome, 3) the values of the outcome are statistically independent, and 4) there are no 
influential points. Collinearity was checked for all predictor and outcome variables, and any 
variable with a high correlation coefficient of ≥ 0.8 was eliminated. All potential predictors with 
modest association with ER visits (p-value ≤ 0.25) were included in the multiple logistic regression 
model. Thereafter, the adjusted model was created using backward selection technique with a p-
to-stay value of 0.25 or less. The step-wise backward elimination began with the least significant 
predictor, and the variables were removed one at a time. The MedMaIDE total score was kept in 
the model regardless of its significance. The odds ratio for each level of categorical variables as 
well as for continuous variables with 95 % confidence interval (CI) and p-value were reported for 
both unadjusted and adjusted models. In addition, the final model fit was evaluated using Hosmer 
and Lemeshow Goodness-of-Fit test.  
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CHAPTER FIVE 
RESULTS 
5.1 Descriptive Results  
It was initially planned to recruit 25% of the total enrollees belonging to RHWP which 
would have been about 87 residents. However, many more residents were screened within three 
months (July – August) than originally anticipated (113 residents). During this time period, 109 
residents successfully completed the full study interview. The data of 107 participants were 
included in the final study analysis as described in Figure 5.1. 
Figure 5.1 Process of Recruitment and Screening  
  
113 residents were primarily 
screened for eligibility 
4 residents did not complete the 
study interview because they did 
not come back for study interview 
109 residents completed the full 
study interview 
107 residents were eligible to be 
included in the final study analysis 
2 residents were excluded after 
conducting the study interview  
 One resident was 50 years old 
 One was using donepezil 5 mg 
tablet once daily    
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In this study, the mean participant age was 68.54 years (±7.23) with a minimum age of 55 
and a maximum of 89 years. Most of the participants were African-American (89%) who lived on 
their own independently (96%) in one of the five senior low-income housings. About 29% of 
participants did not complete high school or GED, 42% completed high school or the GED, and 
31.78% had college education. There were 64 participants (59.81%) with dual eligible insurance 
coverage by Medicaid and Medicare. Moreover, 14 (13.08%) of participants were covered by 
Medicaid alone or other insurance, but not Medicare and 26 (24.30%) had Medicare alone or other 
insurance but not Medicaid. While only three participants (2.80%) were not eligible for either 
Medicaid or Medicare, they received medical care through a coordinated care program for 
uninsured people (Table 5.1).   
The mean total functional comorbidities index was 4.92 (±2.85). Arthritis was the most 
common comorbidity (61.68%) reported by the participants followed by visual impairment such 
as cataracts, glaucoma, and macular degeneration (48.6%), obesity (44.86%) and upper 
gastrointestinal disease (42.99%). Table 5.2 summarizes the participants’ medical history 
measured by FCI.  
During the study interview, the participants brought on average 7.73 (±4.12) medications, 
the minimum was one prescription or OTC medication and a maximum of 21 medications.  About 
73% of them were using five or more prescription medications while 96.26% were using at least 
four OTC medications and 88.79% were taking at least one vitamin. The mean total doses that 
were taken by the participants was 8.13 (±5.11) per day.  The mean score for MRCI was 13.95 
(±8.64), with a maximum of 36.50 MRCI score.  
Regarding medication adherence barriers, 47 participants (43.93%) reported having at least 
one difficulty with their medications such as trouble reading the prescription labels, opening the 
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medication bottles, refilling medication on time, or paying for medications. Only 20.56% (22 
participants) of the study participants reported receiving assistance with these issues from someone 
such as family members, friends, RHWP, or primary care physician (PCP) office. However, 
64.49% of participants reported not missing a dose of any of their medications in the last 7 days 
and about 42% rated their ability to take their medications during the past 4 weeks as excellent 
(Table 5.3). Using medication/drug organizers was the most common medication aid that was used 
by the study participants, in particular, 7-day pill box organizers. The second most popular was 
having medication lists/cards and the least popular was medication reminders either using calendar 
reminders or mobile applications. Thirty-two participants (29.91%) used prescription home 
delivery or mail order to fill their medications, while only 26 (24.30%) reported enrolling in 
medication synchronization services (Table 5.4).  
The health literacy assessment showed that 46 participants (43%) had low or inadequate 
health literacy. The Mini-Cog total scores indicated that 33 (30.84%) participants had possible 
impaired cognitive function, while the total ADL scores indicated that 26 (24.30%) participants 
had moderate to low functional status. The fall rate was 11.21% over the last month. However, the 
majority of the participants used eyeglasses 87 (81.31%), either for reading or distance vision, and 
almost half (51.40%) were using some sort of assistive devices. About 25% of the participants had 
felt depressed over the last week (Table 5.5).   
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Table 5.1 Participants’ Demographic Characteristics by MedMaIDE Score  
Demographic Characteristics 
Data 
summary, 
mean (±SD)  
Pearson 
Correlation 
Coefficients 
P-value 
Age, years (range 55-89) 68.54 (7.23) 0.10 0.2917 
 
Data 
summary,  
N (%) 
Mean (±SD) P-value 
Age    0.0774 
55 - 64 years old 
65 - 74 years old 
75 years or older 
31 (28.97) 
58 (54.21) 
18 (16.82) 
3.10 (2.23) 
2.64 (1.85) 
3.83 (1.86) 
 
Sex   0.8821 
Female  
Male 
55 (51.40) 
52 (48.60) 
3.00 (2.20) 
2.94 (1.78) 
 
Race   0.4877 
White  
Black  
Other (1 Hispanic & 2 Native American)     
15 (14.02) 
89 (83.18) 
3 (2.80) 
3.00 (2.59) 
2.92 (1.89) 
4.33 (2.08) 
 
Marital Status    0.8530  
Single (never married) 
Married  
Separated  
Divorced 
Widowed   
50 (46.73) 
2 (1.87) 
7 (6.54) 
31 (28.97) 
17 (15.89) 
3.18 (2.23) 
2.00 (0.00) 
2.71 (1.70) 
2.81 (2.01) 
2.88 (1.49) 
 
Educational Levels    0.0145* 
Less than high school diploma 
High school /GED 
Some college  
College degree graduated  
31 (28.97) 
42 (39.25) 
24 (22.43) 
10 (9.35) 
3.26 (1.69) 
3.48 (2.25) 
2.21 (1.77) 
1.80 (1.32) 
 
Type of Insurance   0.6675 
Medicaid only 
Medicare only 
Dual eligible  
Other  
14 (13.08) 
26 (24.30) 
64 (59.81) 
3 (2.80) 
2.57 (1.70) 
2.81 (1.83) 
3.16 (2.16) 
2.33 (0.58) 
 
Living Arrangement    0.4298 
Alone  
With other  
103 (96.26) 
4 (3.74) 
2.94 (1.99) 
3.75 (2.06) 
 
Health Status    0.8753 
Excellent/Very Good  
Good  
Fair/Poor   
31 (28.97) 
37 (34.58) 
39 (36.45) 
3.00 (1.95) 
3.08 (2.14) 
2.85 (1.94) 
 
* Significant P-value < 0.05  
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Table 5.2 Participants’ Medical History (Comorbidity) by MedMaIDE Score  
Comorbidities  
Data 
summary, 
mean (±SD) 
Pearson 
Correlation 
Coefficients 
P-value 
Comorbidities (FCI)  (range 0 – 14) 4.92 (2.85) 0.08  0.3882 
Weight, pounds (range 100 -313) 187.81 (44.11) -0.09 0.3504 
Height, Inches (range 53 76) 66.37 (4.02) -0.04 0.6919 
BMI (range 16.74 -50.42) 30.17 (7.39) -0.06  0.5277 
Comorbidities 
Data 
summary,  
N (%) 
Mean (±SD) P-value 
Arthritis    0.7781 
Yes  
No 
66 (61.68) 
41 (38.32) 
3.02 (2.03) 
2.90 (1.96) 
 
Visual impairment    0.1939 
Yes  
No  
52 (48.60) 
55 (51.40) 
3.23 (2.06) 
2.73 (1.92) 
 
Obesity/ BMI > 30   0.4590 
Yes  
No 
48 (44.86) 
59 (55.14) 
2.81 (2.06) 
3.10 (1.95) 
 
Upper gastrointestinal disease    0.6473 
Yes  
No 
46 (42.99) 
61 (57.01) 
2.87 (2.17) 
3.05 (1.87) 
 
Depression   0.2282 
Yes  
No 
41 (38.32) 
66 (61.68) 
3.27 (2.25) 
2.79 (1.82) 
 
Diabetes types I and II   0.9182 
Yes  
No 
36 (33.64) 
71 (66.36) 
3.00 (1.88) 
2.96 (2.07) 
 
Anxiety or panic disorders   0.6097 
Yes  
No 
35 (32.71) 
72 (67.29) 
3.11 (2.39) 
2.90 (1.79) 
 
Congestive heart failure    0.6090 
Yes  
No 
34 (31.78) 
73 (68.22) 
3.12 (2.08) 
2.90 (1.97) 
 
Degenerative disc disease    0.2423 
Yes  
No 
32 (29.91) 
75 (70.09) 
2.62 (2.06) 
3.12 (1.97) 
 
Asthma   0.1297 
Yes  
No 
28 (26.17) 
79 (73.83) 
3.46 (2.38) 
2.80 (1.83) 
 
COPD or Emphysema   0.5901 
Yes  
No 
24 (22.43) 
83 (77.57) 
3.17 (1.81) 
2.92 (2.05) 
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Comorbidities 
Data 
summary,  
N (%) 
Mean (±SD) P-value 
Peripheral vascular disease   0.2577 
Yes  
No 
23 (21.50) 
84 (78.50) 
3.39 (1.90) 
2.86 (2.02) 
 
Hearing impairment    0.1315 
Yes  
No 
22 (20.56) 
85 (79.44) 
3.54 (2.26) 
2.82 (1.91) 
 
Stroke or TIA   0.0314* 
Yes  
No 
21 (19.63) 
86 (80.37) 
3.81 (2.50) 
2.77 (1.81) 
 
Heart attack (MI)   0.7219 
Yes  
No 
12 (11.21) 
95 (88.79) 
3.17 (1.40) 
2.95 (2.06) 
 
Osteoporosis   0.6718 
Yes  
No 
5 (4.67) 
102 (95.33) 
2.60 (1.95) 
2.99 (2.01) 
 
Neurological disease    0.9888 
Yes  
No 
1 (0.93) 
106 (99.07) 
3.00 (0.00) 
2.97 (2.01) 
 
* Significant P-value < 0.05  
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Table 5.3 Medication-Taking Behavior by MedMaIDE Score  
Variables  
Data 
summary, 
mean (±SD) 
Pearson 
Correlation 
Coefficients 
P-value 
Number of meds (range 1 – 21) 7.73 (4.12) 0.18 0.0707 
Number of Rx (range 0 – 19) 6.92 (3.70) 0.15 0.1224 
Number of OTC (range 0 -10) 0.82 (1.60) 0.10 0.3263 
Number of vitamins, minerals & supplements 
(range 0 – 5)  
0.64 (0.94) 0.08 0.4411 
Number of daily doses (range 0 – 24) 8.13 (5.11) 0.088 0.3665 
Medication Regimen Complexity (range 2 – 
36.50) 
13.95 (8.64) 0.11 0.2638 
 
Data 
summary, 
N (%) 
Mean (±SD) P- value 
Polypharmacy    0.0610 
4 or less meds  
5 or more meds  
29 (27.10) 
78 (72.90) 
2.38 (1.84) 
3.19 (2.02) 
 
Medication Adherence Barriers 
Trouble Reading Rx labels   0.0003* 
Yes  
No 
22 (20.56) 
85 (79.44) 
4.32 (1.94) 
2.62 (1.87) 
 
Trouble Opening Rx bottles    0.0001* 
Yes  
No  
13 (12.15)  
94 (87.85) 
4.92 (2.50) 
2.70 (1.77) 
 
Trouble Refiling meds on time   0.2884 
Yes  
No  
11 (10.28)  
96 (89.72) 
2.36 (1.75) 
3.04 (2.02) 
 
Trouble Paying for meds   0.1728 
Yes  
No  
18 (16.82)  
89 (83.18) 
2.56 (1.20) 
3.06 (2.12) 
 
Medication Non-adherence     
Missing a dose of any medication    0.9189 
None  
One dose  
Two or more doses 
69 (64.49) 
17 (15.89) 
21 (19.63) 
2.91 (1.93) 
3.06 (2.68) 
3.10 (1.70) 
 
Ability to take meds as prescribed    0.0251* 
Excellent (adherent)  
Not Excellent (Not adherent)   
45 (42.06) 
62 (57.94) 
2.47 (1.67) 
3.34 (2.14) 
 
* Significant P-value < 0.05 
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Table 5.4 Receiving Assistance with Medications or Using Pharmaceutical Aid/Service by 
MedMaIDE  
Variables  
Data 
summary, N 
(%) 
Mean 
(±SD) 
P- value 
Receiving assistance with medication form someone 
Reminder to take meds    0.0098* 
Yes  
No  
6 (5.61)  
101 (94.39) 
5.00 (2.45) 
2.85 (1.68) 
 
Setting up meds in advance    0.6162 
Yes  
No  
9 (8.41)  
98 (91.59) 
3.44 (2.92) 
2.93 (1.67) 
 
Ordering refills   0.2025 
Yes  
No  
12 (11.21)  
95 (88.79) 
2.88 (1.67) 
3.67 (1.82) 
 
Receiving assistance with meds    0.1454 
Yes  
No 
22 (20.56) 
85 (79.44) 
3.68 (2.64) 
2.79 (1.77) 
 
Medication aids are used     
Medication list/card   0.1010 
Yes  
No 
45 (42.06) 
62 (57.94) 
2.60 (2.02) 
3.24 (1.96) 
 
Med/drug organizer    0.5172 
Yes  
No  
47 (43.93) 
60 (56.07) 
2.83 (1.87) 
3.08 (2.10) 
 
Type of  medication/drug organizer is used, (n=47) 
1-day pill box organizer (daily)   
7-day pill box organizer (weekly)  
14 –day pill box organizer  
Dose pill pouch   
 
2 (4.26) 
42 (89.36) 
2 (4.26) 
1 (2.13) 
  
Med/drug reminder    0.7258 
Yes  
No  
7 (6.54) 
100 (93.46) 
2.71 (1.80) 
2.99 (2.02) 
0.7258 
Type of reminder is used, (n=7) 
Calendar 
Application on your phone  
 
4 (57.14) 
3 (42.86) 
  
Pharmacy services ordered or used  
Special packaging (bubble pack)   0.0277* 
Yes  
No  
7 (6.54) 
100 (93.46) 
4.57 (2.44) 
2.86 (1.93) 
 
Easy to open caps (non-child resistant caps)   0.3825 
Yes  
No  
10 (9.35) 
97 (90.65) 
3.50 (2.17) 
2.92 (1.98) 
 
Large print labels    0.3236 
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Yes  
No  
1 (0.93) 
106 (99.07) 
1.00 (0.00) 
2.99 (2.00) 
 
Medication synchronization    0.6760 
Yes  
No  
26 (24.30) 
81 (75.70) 
3.12 (2.09) 
2.93 (1.98) 
 
Prescription home delivery (mail order)     0.3494 
Yes  
No  
32 (29.91) 
75 (70.09) 
3.25 (1.85) 
2.85 (2.06) 
 
Using pharmaceutical aids or Services    0.2818 
None  
One aid or service  
More than one  
22 (20.56) 
35 (32.71) 
50 (46.73) 
3.32 (1.96) 
2.54 (1.80) 
3.12 (2.13) 
 
* Significant P-value < 0.05  
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Table 5.5 Geriatric Assessments by MedMaIDE Score  
 
* Significant P-value < 0.05  
Geriatric Assessments  
Data summary, 
N (%) 
Mean (±SD) P- value 
Health literacy   0.0002* 
High/adequate health literacy  
Low/inadequate health literacy  
61 (57.00)  
46 (43.00) 
2.33 (1.62) 
3.83 (2.14) 
 
Mini-cog: 3-item recall    0.9729 
1 ≤ words  
2 ≥ words  
25 (23.36) 
82 (76.64) 
2.96 (1.88) 
2.98 (2.04) 
 
Mini-cog: Clock drawing test    0.6809 
Normal  
Abnormal  
65 (60.75) 
42 (39.25) 
2.91 (1.97) 
3.07 (2.05) 
 
Cognitive status    0.4088 
Possible impairment  
No impairment  
33 (30.84) 
74 (69.16)  
3.21 (2.03) 
2.87 (1.99) 
 
Functional status (ADL)   0.0339* 
Highly independent  
Moderate/low independent  
81 (75.70) 
26 (24.30) 
2.74 (1.85) 
3.69 (2.29) 
 
Fall in the last month    0.0533 
Yes  
No  
12 (11.21) 
95 (88.79 
4.50 (2.71) 
2.78 (1.82)  
 
Using assistive devices   0.0210* 
Yes  
No  
55 (51.40) 
52 (48.60) 
3.40 (2.20) 
2.52 (1.66) 
 
Wearing eye-glasses   0.3503 
Yes  
No  
87 (81.31) 
20 (18.69) 
2.89 (2.07) 
3.35 (1.63) 
 
Type of eyeglasses, (n=87) 
Distance vision only  
Reading only  
Both  
 
5 (5.75) 
41 (47.13) 
41 (47.13) 
  
Depression status (GDS-15)   0.5984 
Normal  (≤ 5) 
Depression  (≥ 5) 
80 (74.77) 
27 (25.23) 
2.91 (1.93) 
3.15 (2.21) 
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5.2 Deficiencies in Medication Self-Management Capacity 
On average approximately eight (±4.12) medications were brought by the participants for 
reviewing during the study interview. The study participants had about three (±2.00) total mean 
deficiency score as assessed by MedMaIDE. While some participants had no deficiencies, some 
of them recorded as many as 10 deficiencies in their MMC. On MedMaIDE, the first are assesses 
medication knowledge (i.e. recalling medication names, indications, and doses), the second area 
assesses medication-taking ability (i.e. opening medication vials, removing doses from packaging, 
filling a glass of water), and the third area determines patients’ knowledge about ongoing supply 
of medications (i.e. identifying refills, having transportation to pharmacy). The mean deficiency 
sub-score for the first area was 2.17 (± 1.55). However, the mean sub-score for the second area 
was 0.22 (± 0.63) and the third area was 0.58 (± 0.71). Table 5.6 summarizes the MedMaID 
deficiencies scores.  In addition, 69.16% of the participants were not able to name their 
medications, about 46% did not know the indication, and 38.32% of them could not state the 
correct dose or frequency for their medications.  Furthermore, 41 participants (38.32%) were not 
able to identify the number of refills remaining on the prescription label (Table 5.7).   
Table 5.6 MedMaIDE Deficiencies Scores  
Deficiencies score Mean (±SD) Minimum – maximum 
1st area sub-score  2.17 (1.55) 0 – 5  
2nd area sub-score  0.22 (0.63) 0 – 4  
3rd area sub-score  0.58 (0.71) 0 – 3  
Total score  2.97 (2.00) 0 – 10  
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Table 5.7 Medication Management Skills Assessed by MedMaIDE 
MedMaIDE items N (%) 
1st area: Deficiency in what should be known about medications 
1. Name all medications   74 (69.16) 
2. State the time of the day for each medication 41 (38.32) 
3. State how the medication should be taken 26 (24.30) 
4. State why each medication is taken  50 (46.73) 
5. Tell me the amount should be taken each time  41 (38.32) 
2nd area: Deficiency in how should medications be taken 
1. Fill a glass of water    2 (1.87) 
2. Remove top from the medication container   10 (9.35) 
3. Count out the required number of pills into hand or cup  1 (0.93) 
4. Demonstrate administration of each medication   3 (2.83) 
5. Sip enough water to swallow medication   8 (7.48) 
3rd area: Deficiency in what should be known to get medication refills  
1. Identify existing refills on a prescription    41 (38.32) 
2. Identify who to contact to get a prescription refilled   8 (7.48) 
3. Have resources to obtain the medications  13 (12.15) 
 
5.3 Predictors for Low MMC   
The association between MedMaIDE total deficiency score and the demographic 
characteristics were reported in Table 5.1. The mean MedMaIDE total deficiency score was 
significantly different across participants’ educational level groups. The participants’ with high 
school or less had a significantly higher mean of total deficiency score compared to those who had 
some college or graduated from college.  
There was a positive linear relationship between the mean total of comorbidities and 
MedMaIDE scores, however, this relationship was not statistically significant. Moreover, none of 
the comorbidities were associated with MedMaIDE total deficiency scores except stroke or 
transient ischemic attack (Table 5.2). Participants’ who did not report stroke had a significantly 
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lower mean of total deficiency scores compared with those who reported stroke with a significant 
mean difference of  - 0.22 (95% CI: -1.44, - 0.99).   
There were trends of a positive linear relationship between total deficiency score and 
number of medications, total daily doses taken, and medication regimen complexity (Table 5.3). 
Therefore, the deficiency in the ability to self-manage medication increases as the number of 
medications, daily doses, and medication regimen complexity increased.  Moreover, the mean 
MedMaIDE total deficiency score was higher among those participants who reported using five or 
more medications than those who used four or fewer medications. However, this mean difference 
was not statistically significant [mean difference = - 0.81, (95% CI: -1.66, 0.04)]. 
There was a significant association between MedMaIDE total deficiency score and having 
trouble reading prescription labels and opening the medication bottles (Table 5.3). Participants 
who reported having trouble reading the labels and opening their medication bottles had 
significantly lower ability to manage their medications compared to other participants.  The mean 
difference of total deficiency score was – 1.70 (95% CI: - 1.59, - 0.80) for those with trouble 
reading the labels and – 2.22 (95% CI: - 3.32, - 1.13) for those with trouble opening their 
medications bottles. Adherent participants who rated their ability to take their medications in the 
last four weeks as excellent had significantly lower total deficiency scores compared to others 
[mean difference = - 0.87; 95% CI (- 1.63, - 0.11)]. 
The mean MedMaIDE total deficiency score was not significantly different between those 
who received assistance with medications and those who did not (Table 5.4). However, the total 
deficiency score for those participants who had someone reminding them to take their on a regular 
basis was significantly higher than those who did not [mean difference = - 2.15; 95% CI (- 3.77, - 
0.53); p-value = 0.010]. There was no significant association between MedMaIDE total deficiency 
Page 98 of 155 
 
score and using pharmaceutical aids/services except ordering special packaging for medication 
(i.e. bubble pack). Participants who reported using bubble pack packaging had a significantly 
higher deficiency in their ability to manage their medications compared to others (mean difference 
= - 1.71; 95% CI: - 3.23, - 0.19).  
Low or inadequate health literacy was significantly associated with higher MedMaIDE 
total deficiency score [mean difference = - 1.50; 95% CI (- 2.25, - 0.75); p-value = 0.0002]. 
Participants’ cognitive function was not significantly associated with total deficiency score on 
MedMaIDE while there was a significant association with their functional status as measured by 
ADL. The participants who reported full ability to perform activities of daily living had 
significantly higher ability to self-manage their medications (mean difference = - 0.95; 95% CI: - 
1.83, - 0.07). Furthermore, using assistive devices was significantly associated with a higher mean 
total deficiency score (mean difference = - 0.88; 95% CI: - 1.63, - 0.14). Participants who reported 
falls had a higher mean deficiency score compared with those who did not. However, this was not 
statistically significant (mean difference = - 1.72; 95% CI: - 3.47.63, - 0.03). Table 5.5 summarizes 
the association between MedMaIDE total deficiency score and Geriatric assessment variables. 
In the bivariate analysis, the continuous variable of age was approximately normally 
distributed on the histogram and q-q plot for the residual. Therefore, the quadratic and categorical 
variables of age were tested, and no forms of age variables were significant. However, the 
categorical variable of age was included in the regression models because it showed a modest 
association with the outcome (p-value = 0.0719). The bivariate analyses showed that none of the 
demographic variables were significantly associated with the mean total deficiency score except 
educational level. The mean total deficiency score of MedMaIDE among the participants with an 
educational level less than high school was on average 1.46 points, and those with an educational 
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level equal to high school or GED was on average 1.68 points higher than those with higher 
educational levels (Table 5.8). The adjusted model showed that only education level significantly 
predicted the participants’ deficiency in medication management ability when adjusted for age and 
race. The mean total deficiency score on MedMaIDE was higher by an average of 1.84 points 
among the participants who had less than high school education and by 1.44 points among those 
with high school education when age and race were controlled (Table 5.8).  
The bivariate analyses showed that the linear relationship between the number of 
comorbidities and total deficiency score was not significant. Moreover, only the participants who 
had had a previous stroke scored higher by an average of 1.04 points on MedMaIDE compared to 
those who did not. The adjusted model indicated that having asthma, stroke, and hearing 
impairment were significant predictors for the low ability to self-manage medications. The 
MedMaIDE total score increased by approximately one point on average among the participants 
with asthma, stroke, or hearing impairment (Table 5.9).   
Table 5.10 summarizes the findings of unadjusted and adjusted models for MMC with 
medication-taking behavior variables. The unadjusted model suggested that the association 
between MedMaIDE total deficiency score and having trouble reading prescription labels or 
opening medication containers were significant. Participants who reported having difficulty 
reading the labels on the prescription bottles had a higher mean total deficiency score by an average 
of 1.70, compared to those who did not. Moreover, those who reported difficulties opening their 
medication vials or containers had a higher mean total deficiency score by an average of 2.22 
compared to those who did not. Moreover, medication non-adherence, as assessed by asking the 
participants to rate their ability to take their medication as prescribed in the last four weeks, was 
significantly associated with medication management capacity. Those participants who were not 
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adherent had a significantly higher MedMaIDE total deficiency score by an average of 0.87 scores 
compared to adherent participants. The adjusted model for medication-taking behavior variables 
showed that reporting trouble reading prescription labels and opening medication bottles were 
significant predictors for poor medication self-management capacity. The total deficiency score 
increased by more than one point on average among the participants who reported difficulty 
reading the labels on the prescription bottles and opening the bottles.   
In the bivariate analyses, health literacy, ADLs, fall, and using assistive devices were 
significantly associated with the mean total deficiency score of MedMaIDE (Table 5.11). The 
mean total deficiency score of MedMaIDE increased by 1.50 points among the participants who 
had low or inadequate health literacy compared to those who had high or adequate health literacy. 
Compared to those participants who were fully independent as assessed using ADLs, those with 
moderate or low ADL scores had a significantly higher deficiency in their ability to manage their 
medications by an average of 0.95 points. Participants who reported a fall in the last month or 
using an assistive device, had a total deficiency score on MedMaIDE that was significantly higher 
(by an average of 1.72 and 0.88 points, respectively) than others who did not. In the adjusted linear 
regression model, health literacy, ADLs, and fall were significant predictors for high MedMaIDE 
total deficiency scores. Reporting low health literacy or having a fall significantly increased 
participants’ inability to manage their medication by more than one point on average. Having 
moderate or low ADL function significantly increased the total deficiency score by less than one 
point on MedMaIDE (0.83 points).  
The final adjusted model was built using all the significant variables from all the previous 
models (4 models). The significant predictors that were used to build the final model are 
participants’ education level, having asthma, stroke, and/or hearing impairment, having trouble 
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reading prescriptions labels and opening prescription bottles, health literacy, ADLs, and falling. 
The final adjusted model showed that an education level of high school or less, difficulties reading 
prescription labels or opening the medication bottles, and low or inadequate health literacy were 
the significant predictors for high deficiency in the medication management capacity. The total 
deficiency score of MedMaIDE increased by more than one point on average among those 
participants who reported having high school education or less and reported difficulties reading 
the prescription labels or opening the medication bottles. The mean total deficincy score of 
participants with low health literacy increased by less than one point when compared with 
participants who had higher or adequate health literacy (Table 5.12).   
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Table 5.8 Unadjusted and Adjusted Linear Regression models of Total MedMaIDE Deficiency 
Score and Demographic Characteristics  
 Unadjusted Model Adjusted Model 
 
Parameter 
Estimate (SE) 
P-Value 
Parameter 
Estimate (SE) 
P- Value 
Age   0.0774  0.1373 
55 - 64 years old 
65 - 74 years old 
75 years or older 
- 
- 0.45 (0.43) 
0.74 (0.58) 
- 
0.2970 
0.2093 
- 
- 0.46 (0.42) 
0.56 (0.42) 
- 
0.2729 
0.3157 
Sex      
Male  
Female  
- 
0.06 (0.38) 
- 
0.8821 
  
Race     
White  
None white  
- 
- 0.03 (0.55) 
 
0.9530 
- 
-0.81 (0.56) 
0.1437 
Marital Status   0.3095   
Ever married  
Never married  
- 
0.39 (0.38) 
-  
0.3084 
  
Educational Level   0.0123*  0.0114* 
College degree 
Some College 
High School/GED 
Less than high School  
- 
0.41 (0.71) 
1.68 (0.66) 
1.46 (0.69) 
- 
0.5658 
0.0117* 
0.0338* 
- 
0.50 (0.71) 
1.84 (0.69) 
1.44 (0.73) 
- 
0.4841 
0.0080* 
0.0481* 
Type of insurance   0.6555   
Other  
Medicaid 
Medicare  
Dual eligible  
- 
0.24 (1.26) 
0.47 (1.20) 
0.82 (1.17) 
- 
0.8496 
0.6934 
0.4802 
  
Living Arrangement   0.4243   
With Other  
Alone  
-  
- 0.81 (1.01) 
- 
0.4236 
  
Health Status   0.8719   
Excellent/Very good  
Good  
Fair / Poor   
- 
0.08 (0.48) 
- 0.15 (0.48) 
- 
0.8668 
0.7474 
  
* Significant P-value < 0.05 
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Table 5.9 Unadjusted and Adjusted Linear Regression Models of MeMaIDE Total Deficiency 
Score and Comorbidities 
 Unadjusted Model  Adjusted Model 
Comorbidities 
Parameter 
Estimate (SE) 
P-value 
Parameter 
Estimate (SE) 
P- value 
Arthritis  0.11 (0.40) 0.7755   
Asthma  0.67 (0.43) 0.1231 0.86 (0.42) 0.0412* 
COPD or Emphysema  0.25 (0.46) 0.5854   
Congestive heart failure  0.21 (0.41) 0.6045   
Heart attack (MI)  0.22 (0.61) 0.7186   
Stroke or TIA  1.04 (0.47) 0.0277* 1.19 (0.46) 0.0101* 
Peripheral vascular disease  0.53 (0.47) 0.2507 0.76 (0.45) 0.0919 
Diabetes types I and II  0.04 (0.41) 0.9173 -0.50 (0.40) 0.2174 
Upper gastrointestinal disease  -0.18 (0.39) 0.6433   
Depression  0.48 (0.39) 0.2211 0.57 (0.45) 0.2048 
Anxiety or panic disorders  0.21 (0.41) 0.6052   
Visual impairment 0.50 (0.38) 0.1868   
Hearing impairment  0.72 (0.47) 0.1249 0.90 (0.45) 0.0464* 
Degenerative disc disease  -0.49 (0.42) 0.2353 -0.57 (0.40) 0.1564 
Obesity and/or BMI > 30  -0.29 (0.39) 0.4531 -0.44 (0.38) 0.2420 
Number of comorbidities 0.10 (0.07) 0.2029   
Note: the reference for all comorbidities is “No vs. Yes”, and for the number of comorbidities is “One-Comorbidity 
Increase).  
* Significant P-value < 0.05 
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Table 5.10 Unadjusted and Adjusted Linear Regression Models of MedMaIDE Total Score and 
Medication-Taking Behavior  
 Unadjusted Model  Adjusted Model  
Variable (reference)  
Parameter 
Estimate (SE) 
P-value 
Parameter 
Estimate (SE) 
P-value 
Medication History     
Number of meds (1-med increase) 0.09 (0.05) 0.0707 0.06 (0.04) 0.1550 
Number of daily doses (1-dose 
increase) 
0.03 (0.04) 0.3665   
Medication Regimen Complexity (1-
score increase)  
0.03 (0.02) 0.2638   
Medication Adherence Barriers: having trouble with 
Reading Rx labels (no-yes) 1.70 (0.45) 0.0001* 1.33 (0.42) 0.0017* 
Opening Rx bottles (no-yes) 2.22 (0.55) <.0001* 1.40 (0.56) 0.0118* 
Refilling meds on time (no-yes) - 0.68 (0.63) 0.2814 -0.85 (0.56) 0.1308 
Paying for meds (no-yes)  - 0.50 (0.51) 0.3277   
Medication Non-adherence   
Missing a dose of any meds taken   0.9167   
None  
One dose 
Two or more doses  
- 
0.15 (0.54) 
0.18 (0.50) 
- 
0.7864 
0.7129 
  
Ability to take meds as prescribed      
Excellent (adherent)  
Not Excellent (Not adherent)   
- 
0.87 (0.38) 
- 
0.0218* 
-  
0.64 (0.36) 
 
0.0711 
* Significant P-value < 0.05 
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Table 5.11 Unadjusted and Adjusted Linear Regression Models of MedMaIDE Total Deficiency 
Score and Geriatric Assessments Variables   
 Unadjusted Model Adjusted Model 
Variables  
Parameter 
Estimate 
(SE) 
P-value 
Parameter 
Estimate 
(SE) 
P-value 
Health literacy     
High/adequate health literacy  
Low/inadequate health literacy 
- 
1.50 (0.32) 
- 
<.0001* 
- 
1.39 (0.35) 
- 
<.0001* 
Cognitive Status (Mini-Cog)     
Possible impairment  
No impairment 
- 
-0.35 (0.41) 
- 
0.4025 
  
Functional status (ADL)     
Highly independent  
Moderate/low independent 
- 
0.95 (0.44) 
- 
0.0300* 
- 
0.83 (0.40) 
- 
0.0365* 
Fall in the last month (no-yes) 1.72 (0.59) 0.0033* 1.20 (0.55) 0.0289* 
Using assistive devices (no-yes) 0.88 (0.37) 0.0188*   
Wearing eye-glasses (no-yes) -0.46 (0.49) 0.3436 0.53 (0.43) 0.2246 
Depression status (GDS-15)     
Normal  (≤ 5) 
Depression  (≥ 5) 
- 
0.24 (0.44) 
- 
0.5939 
  
* Significant P-value < 0.05 
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Table 5.12 Final Adjusted model of MedMaIDE Total Deficiency Score and Significant Predictors  
 Adjusted model Final adjusted model 
Variables 
Parameter 
Estimate 
(SE) 
P-value 
Parameter 
Estimate 
(SE) 
P-value 
Educational Level   0.0114*  0.0405* 
College degree 
Some College 
High School/GED 
Less than high School  
- 
0.50 (0.71) 
1.84 (0.69) 
1.44 (0.73) 
- 
0.4841 
0.0080* 
0.0481* 
- 
0.47 (0.60)  
1.32 (0.57)  
1.24 (0.61) 
- 
0.4326 
0.0195* 
0.0415* 
Comorbidities  
Asthma (no-yes) 0.86 (0.42) 0.0412*   
Stroke or TIA (no-yes) 1.19 (0.46) 0.0101*   
Hearing impairment (no-yes) 0.90 (0.45) 0.0464   
Medication Adherence Barriers  
Trouble reading Rx labels (no-yes) 1.33 (0.42) 0.0017* 1.18 (0.41) 0.0036* 
Trouble opening Rx bottles (no-yes)  1.40 (0.56) 0.0118* 1.43 (0.51) 0.0047* 
Health Literacy  
High/adequate health literacy  
Low/inadequate health literacy 
- 
1.39 (0.35) 
- 
<.0001* 
- 
0.90 (0.33) 
- 
0.0063* 
Functional Status (ADL)     
Highly independent  
Moderate/low independent 
- 
0.83 (0.40) 
- 
0.0365* 
- 
0.51 (0.37) 
- 
0.1733 
Fall in the last month (no-yes) 1.20 (0.55) 0.0289* 0.80 (0.51) 0.1135 
* Significant P-value < 0.05 
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5.4 Impact of Using Pharmaceutical Aid/Service on MMC 
Although there were only 22 (20.56%) participants receiving assistance with medication 
from someone, the majority of the participants (79.44%) used at least one pharmaceutical 
aid/service. There were 35 (32.71%) participants who used one aid/service, while 50 (46.73%) 
participants used more than one aid or pharmacy services. Drug organizers (pillbox) were the most 
common medication aid used by the participants (n=47, 43.93%) followed by medication lists or 
cards (n=45, 42.06%) and prescription home delivery/mail order (n=32, 29.91%). On the other 
hand, only 12 (11.21) participants had someone assist them with ordering their medications (Table 
5.4).  
Compared to the participants who did not receive assistance with medications, the mean 
MedMaIDE total deficiency score was not significantly different among those participant who 
received assistance with medication from someone. Likewise, the participants who use 
pharmaceutical aid/service had a total deficiency scores that was not significantly different than 
others (Table 5.4). However, mean total deficiency scores were significantly higher among the 
participants who had someone remind them to take their medications on a regular basis than those 
who did not (mean diff = -2.15, 95% CI: -3.77, -0.53). Furthermore, the participants who used 
special packaging, like bubble packaging had significantly higher mean total deficiency scores 
compared to others who did not use special packaging (mean diff = -1.71, 95% CI: -3.23, -0.19). 
The unadjusted models indicated that the mean total deficiency score increased by on 
average 0.89 points when participants receiving assistance with medications from someone. 
MedMaIDE scores decreased by 0.77 points on average among the participant who used one 
pharmaceutical aid or service and by 0.22 in those who used more than one compared to those who 
did not use any (Table 5.13). However, none of these associations were statistically significant.  
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The adjusted model included the significant predictors from specific aim two (education 
level, trouble reading prescription labels, opening medication bottles, and health literacy). In 
addition, some other potential predictors such as the number of diseases, medications taken, and 
daily doses, medication complexity, and cognitive status were included. The adjusted model 
showed that when adjusting for receiving assistance with medication and using pharmaceutical 
aids/services, the participants with high total deficiency scores on MedMaIDE had not completed 
a college education, used more medications on a regular basis, reported difficulty reading the labels 
on their medication vials and opening their medication bottles, and had low health literacy.  
Moreover, using one pharmaceutical aids/services significantly decreased the mean total 
deficiency scores on MedMaIDE by an average of 0.93 points compared to those who did not use 
any (p-value = 0.0285). However, the overall reduction in the total deficiency score among those 
using pharmaceutical aids/services was not statistically significant in the adjusted models (Table 
5.13). It seems like these might be correlated since individuals tend to start using pharmaceutical 
aids because they are having difficulty.  The aids may not improve their medication capacity 
scores, but they may improve overall adherence.  
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Table 5.13 Unadjusted and Adjusted Linear Regression Models of MedMaIDE Total Deficiency 
Score and Using Pharmaceutical Aid/Service     
 Unadjusted Model   Adjusted Model  
Variables Parameter 
Estimate 
(SE) 
P-value 
Parameter 
Estimate 
(SE) 
P-value 
Receiving assistance with meds     
No  
Yes   
- 
0.89 (0.47) 
- 
0.0560 
- 
0.24 (0.38) 
- 
0.5334 
Using pharmaceutical  aid/service    0.0853 
Using none  
Using one  
Using more than 
- 
-0.77 (0.53) 
-0.20 (0.50) 
- 
0.1468 
0.6933 
- 
-0.93 (0.42) 
-0.76 (0.43) 
- 
0.0285* 
0.0764 
Educational Level   0.0114  0.0325* 
College degree 
Some College 
High School/GED 
Less than high School  
- 
0.50 (0.71) 
1.84 (0.69) 
1.44 (0.73) 
- 
0.4841 
0.0080 
0.0481 
- 
0.27 (0.58) 
1.25 (0.55) 
0.99 (0.60) 
- 
0.6421 
0.0236* 
0.0979 
Asthma (no-yes) 0.86 (0.42) 0.0412   
Stroke or TIA (no-yes) 1.19 (0.46) 0.0101   
Hearing impairment (no-yes) 0.90 (0.45) 0.0464 0.46 (0.37) 0.2180 
Number of comorbidities (1-
comorbidity increase)  
0.10 (0.07) 0.2029 -0.09 (0.06) 0.1372 
Number of meds taken (1-med 
increase) 
0.09 (0.05) 0.0707 0.11 (0.04) 0.0127* 
Number of daily doses (1-dose 
increase)  
0.03 (0.04) 0.3665   
MRC (1-point increase) 0.03 (0.02) 0.2638   
Trouble reading Rx labels (no-yes) 1.33 (0.42) 0.0017 1.11 (0.39) 0.0047* 
Trouble opening Rx bottles (no-yes)  1.40 (0.56) 0.0118 1.16 (0.50) 0.0198* 
Health Literacy      
High/adequate health literacy  
Low/inadequate health literacy 
- 
1.39 (0.35) 
- 
<.0001 
- 
0.97 (0.33) 
- 
0.0029* 
Cognitive status (Mini-Cog)     
Possible impairment  
No impairment  
- 
-0.35 (0.41) 
- 
0.4025 
  
Functional status (ADLs)     
Highly independent  
Moderate/low independent 
- 
0.83 (0.40) 
- 
0.0365 
- 
0.63 (0.37) 
- 
0.0902 
Fall in the last month (no-yes) 1.20 (0.55) 0.0289 0.92 (0.49) 0.0632 
* Significant P-value < 0.05  
Page 110 of 155 
 
5.5 Association Between MMC and ER Utilization  
The rate of the Emergency Room (ER) visits over the last six months was 21.5% (n=23), 
however, this might be not sufficient size to test the association between MMC and ER visits. 
Among those ER visits, 17 participants (73.91%) reported only one ER visits while six participants 
(26.09%) reported more than one ER visits within six months. The most common reasons for those 
ER visits were uncontrolled symptoms (15 visits, 65.22%) such as abdominal pain, headache, and 
shortness of breath. Only five visits (21.73%) were due to medication-related problems such as 
running out of medications and adverse drug reactions. While three (13.05%) of them were due to 
other reasons such as a car accident, a suicidal attempt, and falling.  
There was no significant difference in demographic characteristics between ER visit groups 
except in age and educational level. Reported ER visits were significantly higher among the 
participants aged 65 years and older with college or some college education compared with 
younger participants with less education levels (Table 5.14). Moreover, having at least one ER 
visit was significantly higher among the participants who reported having congestive heart failure, 
depression, and anxiety than those who did not. In addition, there was a significant difference in 
the mean total number of comorbidities among ER visit groups (Table 5.15). The mean difference 
in the total number of comorbidities was 1.55 higher among participants with ER visits compared 
to the no ER visit groups (95% CI: -2.85, -0.25).   
The MedMaIDE total deficiency score was lower among the participants who reported ER 
visits compared to those who did not. The mean difference in the MedMaIDE total deficiency 
score was 0.91 (95%CI: 1.97, 0.46, p-value = 0.0536). The sample size might be not sufficient to 
examine this association between MMC and ER visits. Furthermore, ER visit groups had a higher 
mean number of medications, daily doses taken, as well as medication complexity compared to 
the participants in the no ER visits group (Table 5.16). However, none of these differences were 
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statistically significant. There was no significant difference between the two ER visit groups in 
medication-taking behavior variables. Furthermore, geriatric assessments including health 
literacy, cognitive and functional status, history of fall, using assistive devices, wearing eyeglasses, 
and depression status, were not significantly different among the participants in either ER visit 
group (Table 5.17).  
The unadjusted logistic regression model indicated that there was no significant association 
between medication self-management capacity and ER visits. However, as the total deficiency 
score of MedMaIDE increased, the odds of visiting the ER decreased.  Moreover, the odds of 
reporting ER visits within six months increased among the younger participants who were 55 – 64 
years old as well as the participants with college or some college education. Compared to the 
participants aged 65 years and older, the odds of reporting ER visits was 2.93 times higher among 
the participants aged 55- 64 years. Compared to the participants with high school (or less 
education), those with college education (or some college) were 3.07 times more likely to have ER 
visits. For every one comorbidity increase, the odds of reporting ER visits increased by 1.20 times 
(95% CI: 1.02, 1.41). 
The final adjusted model included the potential variables: age, educational level, health 
status, total number of comorbidities, medication and daily doses taken, medication regimen 
complexity, cognitive and functional status, and having depression symptoms. There was no 
significant association between the MedMaIDE total deficiency scores and ER visits, even when 
controlling for participants’ age, educational level, and comorbidities. This adjusted model 
suggested that for every one-score increase in the total deficiency score, the odds of ER visits 
increased by 1.23 times. However, increasing number of comorbidities was the only significant 
predictor for reporting ER visits when adjusting for participants’ age educational level, functional 
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status, and medication self-management capacity (Table 5.18). The final model fit was evaluated 
using the Hosmer and Lemeshow Goodness-of-Fit Test, which indicated that the model had 
adequate fit to the data, and did not deviate significantly from the data (Chi-square =  3.54, P-value 
= 0.8961).  
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Table 5.14 Participants’ Demographic Characteristics by ER Visits  
 ER Visits in the last 6 months  
Demographic Characteristics  
None  
N= 84 (78.50) 
At least one  
N= 23 (21.50) 
 
 Mean (SD) Mean (SD) P-value 
Age 69.24 (7.47)  66 (5.74) 0.0566 
 N (Col %) N (Col %) P-value 
Age    0.0245* 
55 - 64 years old 
65 years or older  
20 (23.81) 
64 (76.19) 
11 (47.83) 
12 (52.17) 
 
Sex    0.3052 
Male  
Female  
43 (51.19) 
41 (48.81) 
 9 (39.13) 
14 (60.87) 
 
Race   0.3065 
White  
None white  
10 (11.90) 
74 (88.10) 
5 (21.74) 
18 (78.26) 
 
Marital Status    0.7243 
Ever married  
Never married  
44 (52.38) 
40 (47.62) 
13 (56.52) 
10 (43.48) 
 
Educational Level    0.0013* 
College degree 
Some College 
High School/GED 
Less than High School  
3 (3.57) 
19 (22.62) 
38 (45.24) 
24 (28.57) 
7 (30.43) 
5 (21.74) 
4 (17.39) 
7 (30.43) 
 
Educational Level   0.0177* 
College degree/some 
High school or less  
22 (26.19) 
62 (73.81) 
12 (52.17) 
11 (47.83) 
 
Type of insurance    0.2531 
Medicaid 
Medicare  
Dual eligible  
Other  
11 (13.10) 
22 (26.19) 
50 (59.52) 
1 (1.19) 
3 (13.04) 
4 (17.39) 
14 (60.87) 
2 (8.70) 
 
Living Arrangement    1.0000 
Alone  
With Other 
81 (96.43) 
3 (3.57) 
22 (95.65) 
1 (4.35) 
 
Health Status    0.4198 
Excellent/Very good  
Good  
Fair / Poor   
25 (29.76) 
31 (36.90) 
28 (33.33) 
6 (26.09) 
6 (26.09) 
11 (47.83) 
 
Health Status   0.2007 
Excellent/Very good/Good 
Fair / Poor   
56 (66.67) 
28 (33.33) 
12 (52.17) 
11 (47.83) 
 
* Significant P-value < 0.05  
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Table 5.15 Participants’ Comorbidities by ER Visits  
 ER Visits in the last 6 months  
Comorbidities 
None  
N= 84 (78.50) 
At least one  
N= 23 (21.50) 
 
 N (Col %) N (Col %) P-value 
Arthritis 49 (58.33) 17 (73.91) 0.1733 
Osteoporosis 2 (2.38) 3 (13.04) 0.0654 
Asthma 23 (27.38) 5 (21.74) 0.5855 
COPD, ARDS, or Emphysema 16 (19.05) 8 (34.78) 0.1089 
Congestive heart failure 22 (26.19) 12 (52.17) 0.0177* 
Heart attack 8 (9.52) 4 (17.39) 0.2828 
Stroke or TIA 15 (17.86) 6 (26.09) 0.3786 
Peripheral vascular disease 19 (22.62) 4 (17.39) 0.7765 
Diabetes types I and II 28 (33.33) 8 (34.78) 0.8963 
Upper gastrointestinal disease 37 (44.05) 9 (39.13) 0.6730 
Depression 28 (33.33) 13 (56.52) 0.0427* 
Anxiety or panic disorders 22 (26.19) 13 (56.52) 0.0060* 
Visual impairment 39 (46.43) 13 (56.52) 0.3908 
Hearing impairment 19 (22.62) 3 (13.04) 0.3942 
Degenerative disc disease 22 (26.19) 10 (43.48) 0.1086 
Obesity and/or (BMI) > 30 36 (42.86) 12 (52.17) 0.4260 
 Mean (SD) Mean (SD) P-value 
Number of comorbidities  4.58 (2.64) 6.13 (3.28)  0.0201* 
* Significant P-value < 0.05 
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Table 5.16 Medication-Related Variables by ER Visits  
 ER Visits in the last 6 months  
 None 
N= 84 (78.50) 
At least one 
N= 23 (21.50) 
 
 Mean (SD) Mean (SD) P-value 
MedMaIDE total deficiency score  3.17 (2.08) 2.26 (1.48) 0.0536 
Number of meds 7.40 (3.97) 8.91 (4.54) 0.1207 
Number of daily doses  7.80 (5.16)  9.35 (4.84)  0.1988 
Medication Regimen Complexity  13.23 (8.37) 16.59 (9.29)  0.0991 
 N (Col %) N (Col %) P-value 
Receiving meds assistance from someone     0.8746 
Yes  
No 
17 (20.24) 
67 (79.76) 
5 (21.74) 
18 (78.26) 
 
Using Pharmaceutical aids/services   0.5270 
Using none  
Using one  
Using more than one  
18 (21.43) 
27 (32.14) 
39 (46.43) 
4 (17.39) 
8 (34.78) 
11 (47.83) 
 
Medication Adherence Barriers   0.3683 
Yes  
No 
35 (41.67) 
49 (58.33) 
12 (52.17) 
11 (47.83) 
 
Reading Rx labels  16 (19.05) 6 (26.09) 0.4592 
Opening Rx bottles  13 (15.48) 0  0.0662 
Refilling meds on time  6 (7.14) 5 (21.74) 0.0559 
Paying for meds  12 (14.29) 6 (26.09) 0.1801 
Medication Non-adherence   
Missing a dose of any meds taken last week   0.2983 
None  
One dose 
Two or more doses  
53 (63.10) 
12 (14.29) 
19 (22.62) 
16 (69.57) 
5 (21.74) 
2 (8.70) 
 
Ability to take meds as prescribed    0.5270 
Excellent (adherent)  
Not Excellent (Not adherent)   
34 (40.48) 
50 (59.52) 
11 (47.83) 
12 (52.17) 
 
* Significant P-value < 0.05 
  
Page 116 of 155 
 
Table 5.17 Geriatric Assessments Variables by ER visits   
 ER Visits in the last 6 months  
 None 
N= 84 (78.50) 
At least one 
N= 23 (21.50) 
 
 N (Col %) N (Col %) P-value 
Health Literacy    0.5970 
High/adequate 
Low/inadequate  
49 (58.33) 
35 (41.67) 
12 (52.17) 
11 (47.83) 
 
Cognitive Function    0.1338 
Possible impairment  
No impairment  
29 (34.52) 
55 (65.48) 
4 (17.39) 
19 (82.61) 
 
Functional Status    0.1822 
Highly independent  
Moderate/Low independent 
61 (72.62) 
23 (27.38) 
20 (86.96) 
3 (13.04) 
 
Using Assistive device  46 (54.76) 9 (39.13) 0.1839 
Fall  9 (10.71) 3 (13.04) 0.7182 
Wearing eyeglasses  68 (80.95) 19 (82.61) 1.0000 
Having depression symptoms    0.2341 
Normal (no depression) 
Depression symptoms  
65 (77.38) 
19 (22.62) 
15 (65.22) 
8 (34.78) 
 
* Significant P-value < 0.05  
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Table 5.18 Unadjusted and Adjusted Logistic Regression Models for ER Visits and Potential 
Predictors  
 Unadjusted Model Adjusted Model 
 OR (95 % CI) 
P-
Value 
OR (95 % CI) 
P- 
Value 
MedMaIDE total deficiency 
score (1-point increase)  
0.77 (0.58, 1.01) 0.0573 0.81 (0.60, 1.10) 0.1809 
Age      
65 years or older 
55 - 64 years old 
- 
2.93 (1.12, 7.66) 
-  
0.0280* 
- 
2.89 (0.96, 8.66) 
- 
0.0583 
Educational Level      
High school or less 
College degree/some 
- 
3.07 (1.19, 7.96) 
- 
0.0207* 
- 
2.59 (0.88, 7.62) 
- 
0.0837 
Health Status   0.2041   
Excellent/very good/good  
Fair/Poor   
- 
1.83 (0.72, 4.67) 
   
Number of comorbidities (1-
comorbidity increase)  
1.20 (1.02, 1.41) 0.0253* 1.25 (1.03, 1.52) 0.0219* 
Number of meds (1-med 
increase) 
1.09 (0.98, 1.22) 0.1241   
Number of daily doses (1-dose 
increase)  
1.06 (0.97, 1.15) 0.2008   
MRC (1-point increase) 1.04 (0.99, 1.10) 0.1025   
Health Literacy     
High/adequate 
Low/inadequate 
- 
1.28 (0.51, 3.24) 
- 
0.5975 
  
Cognitive Function      
Possible impairment  
No impairment  
- 
2.50 (0.78, 8.06) 
- 
0.1235 
  
Functional Status      
Moderate/Low indep. 
Highly independent 
- 
2.51 (0.68, 9.27) 
- 
0.1662 
- 
3.66 (0.81,16.58) 
- 
0.0926 
Fall     
No 
Yes  
- 
1.25 (0.31, 5.05) 
- 
0.7541 
  
Having depression symptoms      
Normal (no depression) 
Depression symptoms  
- 
1.82 (0.67, 4.95) 
- 
0.2380 
  
* Significant P-value < 0.05H 
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CHAPTER SIX  
DISCUSSION AND CONCLUSION 
6.1 Discussion 
To the best of our knowledge, this is the first study examining the relationship between 
MMC and a wide range of variables among older adults living in the subsidized housing 
community. This study adds several findings to the existing literature. First, a resident aged 55 
years or older and living in subsidized housing uses on average approximately eight medications 
that are associated with about five medical conditions. Second, many low-income older adults have 
limited ability to manage their own medications, in particular, they have a lack of knowledge about 
their medications. Third, among members of this group, low educational level, low health literacy, 
and reporting difficulties reading medication labels or opening medication bottles are significant 
risk factors for medication mismanagement. Four, assessing older adults’ ability to manage their 
own medication using a standardized tool like MedMaIDE helps to identify those at risk for 
medication mismanagement and is useful for individualizing interventions based on their needs 
and specific deficiencies.  
 The study sample was recruited from five subsidized housing communities, and they 
represent the common characteristics of the residents of HUD buildings. The study sample was 
more likely to live on their own independently with multiple chronic conditions, and were more 
likely to have limited educational level and health literacy, and reported fair or poor health status.  
The results of this cross-sectional study showed that older adults who live in low-income 
housing communities had an average of about three deficiencies in their medication management 
capacity as assessed using MedMaIDE. Among 107 participants age 55 years or older, 98 (91.59%) 
of them had one or more deficiencies in medication management and 81 (75.70%) had two or more 
deficiencies in medication management.  These findings are higher than what a previous study 
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found using the same assessment tool (Orwig D., et al.).1 The participants of that study were 50 
community-dwelling older adults with an average age of 78.18 (±7.21) and about 9.38 (±3.74) 
years of education, and their annual income ranged from $9,000 to 12,000.1 In that study, the mean 
total deficiency score was approximately two (±1.96), and 70% had one or more deficiencies in 
medication management on MedMaIDE.1 Specifically, the sub-score for the first area was 2.17 
(±1.55) in our study, which is almost double what was found in the previous study [1.46 (±1.54)]. 
These high overall scores might be due to relying on the written directions on the labels to compare 
to what the participants reported when assessing their knowledge about medications.1 As a result, 
one point (unable) was given for any discrepancies that occurred between what was reported by 
the participant and what was written on the labels during the assessment of MMC. Nevertheless, 
credits were given for any appropriate answer reported by the participants when the indication was 
not specified on the labels and the medication had multiple indications. This may increase the sub-
score for the first area as well as the overall score.  Furthermore, the most difficult skill was naming 
the medications followed by stating the indication, timing, frequency, and identifying existing 
refills. These findings are consistent with the previous study. However, the participants in that 
study were older than this study (78.18 vs. 68.54 years). The sample in both studies was highly 
independent, cognitively intact, and used a high number of prescription medications on average 
(approximately ≥ 7 medications on average). Unfortunately, we cannot compare our findings with 
the other studies using MedMaIDE to assess the deficiencies in medication management because 
the participants were caregivers.2,3  
The analysis of this study shows that low educational level, reporting difficulties reading 
the medication labels or opening the medication bottles, and low or inadequate health literacy are 
strong independent predictors for low medication self-management capacity among low-income 
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older adults. These predictors remained significant even after adjusting for all other significant 
predictors in one model.  
We found a robust association between participants’ ability to self-manage their 
medications and educational level. Participants with less than or equal to high school education 
had a significantly higher deficiency in their ability to manage medications compared to those with 
a college education or more. While numerous studies describe the association between educational 
level and medication management, the findings are inconsistent.4–8 One of the previous studies 
showed that the odds of being unable to identify all medications increased 3 times among patients 
with less than 12 years of schooling.4,5 The negative association was seen in the studies that 
included a well-educated sample.4 In contrast, about 68.22% of our sample had less than or equal 
to high school education which can be used as an indicator of living in low socioeconomic status 
(SES). Therefore, our findings may support evidence that has found that low socioeconomic status 
is a risk factor for medication mismanagement.7,8 Also, it is consistent with the idea that education 
level is a social determinant of health.9  
Consistent with the literature, our findings showed that low/inadequate health literacy was 
significantly related to low MMC. An observational study found that patients with inadequate 
health literacy were 18 times more likely to be unable to identify all of their medications compared 
to patients with adequate health literacy.4 Furthermore, other studies have shown that patients with 
low health literacy are unable to understand medication instruction easily.10,11 In a published 
survey for Medicare managed care enrollees, 47.5% of respondents with inadequate health literacy 
were unable to identify the appropriate timing of the dose that was written on the labels, and 54.3% 
inadequate-literacy respondents struggled to explain how to take a medication on an empty 
stomach.11  These findings in combination with our study findings indicate that low health literacy 
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may impact an individual’s cognitive ability to manage medications. Consequently, health care 
providers, in particular pharmacists, should consider the patients’ level of education, health 
literacy, and SES when providing education about medication use.   
In this study, the association between the deficiency in medication management capacity 
and self-reported medication adherence was statistically significant only in the bivariate analysis.  
Reporting trouble reading labels and opening medication bottles was significantly related to the 
deficiency in MMC in both bivariate and multivariate analysis. We found that the participants who 
reported trouble reading labels or opening medication bottles had a higher total deficiency score 
by more than one point on average compared to others who did not report these medication-related 
difficulties. In the literature, there has been a conflict regarding the correlation between MMC and 
both objectively measured and self-reported medication adherence1,8,12,13 The validation study of 
MedMaIDE showed that as the deficiency in medication management increases, the medication 
adherence (based on 30-day pill count) decreases.1 Other studies concluded that patients’ capacity 
to manage meditations does not significantly impact their adherence status. The developers (Murry 
et al.) of the medication assessment instrument (MAI), one of the MMC assessment tools, reported 
a significant association between medication adherence and two skills of medication management 
among community-dwelling older adults.12 These two skills were inability/difficulty to open a flip 
top lid and read a medication label.12 Even though it is not entirely clear why this relationship 
exists, it could be due to the low educational level, visual impairment, having arthritis or any other 
factors. This finding indicates that the pharmacist should check older adult patients’ ability to read 
the details on the label and remove the cap on the medication vials before leaving the pharmacy. 
Thereafter, further investigation should be done to identify the appropriate intervention. Older 
adult patients who live alone are at risk for medication errors when they cannot read the directions 
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on the label or cannot open child-resistant caps. In addition, they may lack assistance with 
medication at home which may put them at higher risk of medication errors.  Therefore, the 
directions on the label of all medications, not just newly prescribed medication, should be reviewed 
with elderly patients before leaving the physicians office and/or pharmacy. In addition, the 
information about the availability of non-child resistant caps and other medication packaging 
should be provided to older adult patients.  
The findings of this study suggested that the association between MMC and the number of 
comorbidities did not exist. This is consistent with what has been reported in existing literature.5,7 
However, we found that specific comorbidities like asthma, stroke and hearing impairment are 
positive predictors for deficiency in medication management when adjusting for other 
comorbidities and number of comorbidities. In general, stroke may contribute to cognitive and 
physical impairments, and arthritis contributes to dexterity issues among older adult patients. In 
addition, patients with asthma and stroke are typically prescribed complicated and multiple 
medication regimens.14 However, our findings indicated that there was a non-significant 
relationship between limited medication management capacity and taking a high number of 
medications and daily doses taken, and complicated medication regimens. These findings are 
consistent with what has been reported previously.5,7,8,15 Therefore, the limited MMC among 
patients with asthma and stroke might not be related to using multiple and complex medication 
regimens. Furthermore, a cross-sectional study observed that using hearing aids does not impact 
older adults’ ability to take oral medication.7 Another study showed that lacking the knowledge 
and skills to manage heart failure medications are related to negative health outcomes.16   
On the bivariate analyses, we observed that limited ability to perform basic ADLs, using 
assistive devices, and a history of falling are positive predictors for deficiency in medication 
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management capacity. However, this was not the case in the multivariate analysis. The MedMaIDE 
validation study found that self-reported ADLs and IADLs were not significantly related to the 
sample’s ability to manage their medication, similar to what has been reported in other studies.1,5 
However, a one year follow up study confirmed a significant relation between MMC and both self-
reported ADLs and IADLs after six months.15  
Unlike other studies, this study failed to observe the significant relationship between MMC 
and participants’ cognitive function.1,4,5,7,8,15 This inconsistent finding with other studies might be 
due to two reasons. First, the Mini-Cog was used in this study to assess cognitive function, while 
most of the previous studies used the Mini-Mental State Examination (MMSE). Second, the 
sample in this study was relatively cognitively intact. The participants who had Alzheimer’s 
disease, dementia, or were taking any medications for memory (such as cholinesterase inhibitors 
and memantine) were excluded. Moreover, a cross-sectional study concluded that the Mini-Cog is 
a significant screening tool for determining patients’ ability to organize a pillbox.  The findings of 
that study showed a weak correlation between MMSE and ability to organize the pillbox.17 Another 
study concluded that impaired concentration and poor visual and verbal memory were predictive 
of poor medication planning ability, while limited motor dexterity and strength was an indicator 
of inability to open the child-resistant cap and cutting pills.18  
Even though the MMSE covers more aspects of cognitive function ─ including orientation, 
word registration, attention and calculation, recall, and language ─ it fails to detect people with 
deficiency in executive cognitive function (ECF). Moreover, individual’s age, educational level, 
literacy, SES, and language affect MMSE scores.19,20 Consequently, older adults who have a low 
educational level or SES, and limited communication skills may score poorly on the MMSE even 
when they are cognitively intact.20,21 On the other hand, the clock drawing test component of the 
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Mini-Cog assessment is specifically designed to assess ECF. Additionally, scoring on the Mini-
Cog is not related to age, educational level, or language.19,20 Since managing a medication regimen 
appropriately requires coordination of simple tasks, like identifying the medication, opening and 
removing the medication from packaging and recalling the dosing time and frequency, it mainly 
depends on an individual’s ECF.21  Therefore, Mini-Cog might be the appropriate screening tool 
to identify people with the required cognitive function to self-manage their medication 
independently.  
Consistent with the literature, older adults’ cognitive and functional ability to manage their 
medication was not influenced by depression symptoms as measured by the GDS.5,7,15 In addition, 
we did not observe a difference in medication management among the participants who were 
diagnosed with depression or anxiety.   
When the residents had someone reminding them to take medication on regular basis, more 
deficiency in medication management was observed than those who did not have assistance 
(MedMaIDE total score: 5.00 (±2.45) vs. 2.85 (±1.68), p-value = 0.0098). In addition, using bubble 
pack packaging was related to a higher deficiency in medication management (4.57 (±2.44) vs. 
2.86 (±1.93), p-value = 0.0277). A study reported patients who were using blister pack and 
receiving reminders from someone to take medications were more likely to have limited ability to 
recall medication instructions.22 When individuals have trouble with medication management are 
often offered specialized packaging like bubble pack as a way to help them.  Using specialized 
packaging may not necessarily improve their knowledge about medications but it helps keeping 
them on schedule. However, the packages may or may not be easier to open depending on the 
packaging system.  In this case, maybe the poor capacity is the cause of getting packaging. 
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Therefore, it helps to improve adherence, but not necessarily by increasing their capacity to 
manage medications especially concerning knowledge of their medications.  
As expected, the findings of this study suggest that using pillbox organization increased 
older adults’ ability to manage their medication. Even though pillbox (43.93%) was the most 
common medication aid used by the participants, the relationship between MMC and using a 
medication organizer aid was not statistically significant. This might be explained by participant 
difficulty organizing or refilling the pillbox, an item that was not captured using MeMaIDE. Even 
though MedMaIDE was designed to assess patients’ ability to manage different dosage forms, it 
does not asses their ability to organize or fill the pillbox. A cross-sectional study concluded that 
patients' cognitive ability to comprehend prescriptions impacts their ability to correctly organize 
and fill the pillbox. This study proposed a new tool (Medi-Cog) as a screening for determining 
pillbox organization ability and identifying patients at risk for medication mismanagement.17 
In our study, limited MMC was observed when the participants reported assistance with 
medications from someone (i.e. reminding them to take medication, setting up the pillbox, or 
ordering there refills). While, high MMC was observed among the participants who used 
medication aids (i.e. drug list/card, organizer, or reminder) or pharmacy services (i.e. special 
packaging, non-child-resistant cap, prescription home delivery, or mail order). However, these 
observations were not statistically significant even when adjusted for other significant predictors 
for self-managing of medications. In the adjusted model, taking a high number of medications 
turned out to be as a positive predictor for deficiency in medication management along with low 
educational level, reporting difficulties reading labels and opening bottles, and limited health 
literacy when adjusted for receiving assistance with medication and using medication aids or 
pharmacy services. However, the literature suggests that using medication aids and medication 
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synchronization programs can improve medication adherence.23,24 Indeed, using at least one 
pharmaceutical aids/services might correlate with low MMC since individuals tend to start 
receiving help or using pharmaceutical aids because they are having difficulty.  The aids and 
assistance with medication may not improve their medication capacity scores, but they may 
improve overall adherence.  
This study shed light on the issue of emergency room utilization among the study sample. 
Since 2012, when RHWP clinics were implemented, the overall rates of ER visits have 
decreased.25 Despite this fact, there were 23 (21.50%) participants who reported ER visits within 
six months before the study interview. The findings suggest that age, educational level, and number 
of comorbidities are significantly associated with ER visits among the study sample. Although the 
association between ER visits and deficiency in medication management was not significant, we 
observed that the deficiency in medication management capacity was higher among the 
participants who reported ER visits compared to those who did not. In addition, an ordinal logistic 
regression model was conducted as a sensitivity analysis to examine whether the deficiency in 
MMC increased the number of ER visits. The ER visits were categorized into three groups: 1) no 
ER visits [84 (78.50%)], 2) one ER visit [17 (15.89%)], and 3) more than one ER visits [6 (5.61%)]. 
The finding of this ordinal logistic analysis showed that the association between MMC and number 
of ER visits was not statistically significant [OR = 0.782 (95% CI: 0.598, 1.023), P-value = 
0.0723].  This finding is not different than that of the logistic regression analysis (ER visit vs. no 
ER visit), which also found no significant difference.  This may be because there is no true 
association between medication management capacity and ER visits or that there was insufficient 
sample size to detect a true difference (Type II error)  
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In contrast, a one-year follow-up study reported that the change in MMC between baseline 
and six months was significantly related to an increased number of ER visits.15  Another 6-month 
follow up study concluded that having limited medication knowledge was significantly associated 
with more ER visits among patients 50 years and older with congestive heart failure.16  
In our study, ER visits were assessed retrospectively, which might not be as accurate as 
other studies that followed patients prospectively. The nature of self-reported data coupled with 
the recall period of six months might be factors that affected the accuracy of the reported number. 
Even though six months seems like a reasonable period for an average healthy person to recall, it 
was clear to the study investigator how difficult it was for some of the participants to recall the 
information. A study that looked at the accuracy of self-reported data of health services utilization 
among older adults who were 65 years concluded that the health services use were under-reported 
by those older adults.26 The finding of that study found that 28.1% of older adults who were 65 
years and older failed to report ER visits over 12 months when compared with electronic record 
data.26 Another justification for our findings is that the vast majority of the participants were 
receiving care from RHWP clinics. Typically, the RHWP team provide a follow-up visit at home 
or at clinic for those participants who reported ER visits.  During this follow-up visit, the 
interprofessional team works with residents to identify any care coordination needs, whether they 
are medication or health-related needs. Thereafter, the team works with the resident to fulfill 
his/her needs, such as providing medication reconciliation, education/counseling about 
medications or health conditions, disease monitoring, or accessing prescription medications or 
healthcare services.25 As a result, those participants with ER visits might be scored low on 
MedMaIDE which indicates having a high ability to manage their medications independently. 
  
Page 128 of 155 
 
6.2 Study Limitations 
To the best of our knowledge, this is the first study examining the relationship between 
MMC and a wide range of variables among older adults living in the subsidized housing 
community. This study has several limitations. First, the study sample size was relatively small, 
which may lead to a type II error. Therefore, this study has low power to detect the significant 
relationship between MMC and some variables. This study intended to study a minority population 
of older adults who live in the low-income housing community, and 107 participants have 
successfully completed the study. We were fortunate to have complete data without any missing 
variables, which increases the study power, despite the small sample size. Further, four separate 
models were conducted to identify the significant predictors of limited MMC to address the sample 
size issue.  
Using a non-probability (non-random) sampling strategy may lead to limited 
generalizability and selection bias due to homogeneity among the sample characteristics. 
Therefore, the findings cannot be generalized to all community-dwelling older adults. The eligible 
age was 55 years or older which may not represent the common chronological age classification 
for older adults in developed countries like the U.S. The sample was recruited from five subsidized 
housing locations in downtown Richmond VA, which serve a predominately vulnerable older adult 
population who lives with a high burden of chronic diseases coupled with economic challenges 
and limited access to health resources. By setting this age criterion, we considered the 
biological/physiological age which is influenced by various factors such as lifestyle, chronic 
diseases, genetics, alcohol consumption, SES, and living location.27 The participants' average age 
was about 68 years, and most were African American (83%) with high school or less education, 
and living with about five medical conditions. Surprisingly, there was an almost equal proportion 
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of male and female participants (48.60 vs. 51.40%, respectively), which may be considered a 
strength for this study. The characteristics of this study’ sample were similar to the characteristics 
of participants in RHWP clinics. Despite our limitations, research in this minority high-risk 
community is needed and may inform future intervention to improve medication self-management 
and increase independence.  In addition, most of our findings were consistent with previous studies 
of MMC performed in different settings.  
Another study limitation is that the nature of the study data might introduce some biases to 
the findings. Self-reported data may be subject to social desirability and recall bias. Furthermore, 
there might be a selection bias due to using a self-selected sample. This sample included mostly 
people with a greater interest in taking medication safely and as prescribed, which might not 
represent the attitudes or behaviors of the general demographic. During the assessment of MMC, 
we relied on the participants to display and report all medications they were using on regular basis 
and on the written directions on the labels of these medications to determine their ability to manage 
medications. Unfortunately, we do not have access to the residents’ medical record or pharmacy 
records, so we may over or underestimate the sample’s MMC. However, we were able to assess 
older adults’ medication knowledge for both prescription and OTC medications. We observed a 
high deficiency in medication management among the study sample. This was somewhat 
surprising because most of the participants were receiving care coordination services from the 
RHWP clinics. In addition, participants’ medical history was assessed using the functional 
comorbidity index which includes only 18 self-reported medical conditions. Thus, we missed 
many chronic conditions/disease that participants might have had that were not included in an 
index designed to predict functional impairment.  
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In this study, MedMaIDE was chosen over a wide number of validated tools that were 
designed to assess MMC for several reasons. One of these reasons is that it evaluates older adults’ 
cognitive and functional abilities to administer/take different dosage forms, not only oral 
medications. However, it does not assess the ability to organize or fill medication organizers such 
as pillboxes, which is one of the study limitations. Pillboxes are the most common medication 
organization tool used by about 10 million older adults.17 Therefore, further study is needed to 
investigate the older adult’s ability to use a pillbox correctly using an appropriate assessment tool. 
Additionally, MedMaIDE might be subject to floor or ceiling effects which occurs when most of 
the participants are scored near the minimum or maximum score.28 However, the total deficiency 
score on MedMaID was normally distributed with a minimum score of 0 and maximum score of 
10. Moreover, MedMaIDE is a performance-based tool using the patient’s own medication. Most 
of the residents were very collaborative and they brought all medications for review, while a few 
of them forgot or decided to bring only some of them. Refrigerated medications (heat sensitive) 
like insulin and controlled medications were the most often forgotten or not brought medications 
for review.   
There was a potential for interviewer bias and measurement bias. However, these types of 
bias cannot be completely excluded. All the interviews were conducted and the data were collected 
by one interviewer, which may control the interviewer bias and minimize the variance in the data.  
The interview procedure and the assessment order was specified in the study protocol, and all the 
study assessments were selected based on validity and reliability data.  
The last limitation is that the study findings may be influenced by other potential 
combinations of mediators or moderators that should be controlled. For example, we assume all 
study participants have low socioeconomic status since the participants met certain celling income 
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criteria for residing in subsidized housing. Whereas financial/income information may determine 
the optimal socioeconomic level, this information is sensitive and not easily obtained as well as 
may be difficult to interpret. As a result, the study findings might be interpreted differently by 
controlling those potential mediators or moderators.  
6.3 Future Direction 
A number of observational studies have been done in this area of medication self-
management, however, most of them were limited to small sample sizes, and had generalizability 
limitations. Future research should be directed toward prospective and interventional studies for a 
larger sample size with a more diverse population. The stronger study design would be randomized 
prospective cohort study. It would be worthwhile to use a random sampling strategy with a 
comparison (control) group to overcome the issues of limited generalizability and selection bias.  
We could randomly select a cohort sample of older adults from nationally representative registry 
data such as HUDs or Medicare data.  
By following up the participants prospectively, we could understand how the cognitive and 
functional ability to appropriately manage medications changes over time. It would be important 
to study how age-related changes in cognitive and functional status affect the ability to manage 
medication independently over time. The power of our study was insufficient to determine the 
relationship between MMC and ER visits. The prospective study design will be more appropriate 
to examine the relationship between patients’ ability to manage medications and clinical outcomes 
such as hospitalization, ER visits, and institutionalization. Furthermore, we could study the 
association between MMC and medication outcomes such as medication errors, and medication 
adherence. It would be interesting to determine the patients’ ability to manage medications using 
two different standardized assessment tools, one of them using the  patients’ own medications and 
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the another using simulated mediations. In addition, a future study could identify the required skills 
and the potential predictors for limited ability to manage pillbox.  
This study found that people with low MMC were more likely to start using medication 
aids or pharmaceutical services which might improve overall adherence but not necessarily 
improve the ability to manage medications. It would be worthwhile to look at the causal 
relationship in future studies where MMC would be compared before and after intervention with 
pharmaceutical services or RHWP clinic visits.  By conducting this experimental design we could 
test the hypothesis of whether or not implementing medication interventions would improve a 
patient's ability to take medications as prescribed. As a result, the role of using a different types of 
medication intervention would be studied including the use of pillbox otherwise specialized 
packaging, prescription home delivery, medication regimen simplification and medication 
counseling. Also, the effectiveness of implementing medication intervention as identified after 
MMC assessments would be determined. Future research in RHWP should examine whether 
medication self-management capacity could predict who might not be able to remain living 
independently safely or who might need additional support to remain independent. This line of 
research would strengthen the evidence on the utility of using a standardized validated tool to 
assess MMC in outpatient settings. The effect of potential mediators and moderators should be 
considered and controlled in the future study.  
Clinical Implications 
The findings of this study would be used to improve the effectiveness of clinical 
assessments that used in RHWP clinics to identify residents' health deficits and determine their 
needs. Medication management is a basic self-care activity, and inclusion of MMC assessment in 
comprehensive geriatric assessments is recommended to promote safe use of medications among 
Page 133 of 155 
 
older adults living independently in low-income senior housing. In this study, the association 
between low MMC and low educational level and health literacy was statistically significant. 
Therefore, screening for health literacy might be a useful clinical assessment to identify those older 
adult residents who should get MMC assessment. The findings showed that the three health literacy 
questions that were used could be a good screening tool. Additionally, questioning the participants  
at RHWP about whether or not they have difficulty opening and reading prescription medications 
can be used to determine those who need a full MMC assessment. Assessing MMC using a 
standardized and validated tool helps to detect the cognitive and functional limitation in medication 
management and target intervention based on needs.  
6.4 Conclusion  
Many older adult residents of low-income housing communities have deficient capacity to 
manage their medications independently. Insufficient medication knowledge is more prevalent 
among low-income older adults. Low educational level and health literacy and reporting difficulty 
reading the prescription labels and opening the medication bottles are contributing factors to 
mediation mismanagement.  This present study adds to the growing body of evidence suggesting 
that assessing older adults’ ability to manage their own medications using a performance-based 
tool such as MedMaIDE may help to identify those individuals with limited medication 
management capacity and lead to individualized intervention thereafter. Healthcare providers, in 
particular pharmacists, should consider assessing older adults’ capacity for self-managing 
medication to identify key targets for interventions, which will promote healthy aging in-place and 
independence by enhancing the safe use of medications. There is a need for additional research 
studying the change in MMC over a long period of time among a larger sample. It would also be 
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useful to study intervention strategies that may improve medication management skills such as 
specialized packaging, pillbox organization, improved labeling, and counseling.
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